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Selenium (Se) is a trace element that is incorporated into proteins in the form of the 21st
amino acid, selenocysteine (Sec). Se supplementation was reported to have beneficial roles in
prevention of cardiovascular and muscle disorders, cancer prevention and enhancement of the
immune function. However, recent studies also showed that excessive dietary Se increases the
risk of development of type 2 diabetes mellitus. Thus, better understanding of Se and
selenoprotein functions is required. We used three approaches to address this problem.
First, we used high-throughput sequencing to examine composition of the gut microflora
in mice maintained on selenium-deficient, selenium-sufficient, and selenium-enriched diets, and
then link information to selenoprotein expression and function. Our data indicate that Se
supplementation affects both the composition of the intestinal microflora and the colonization of
the gastrointestinal tract in germ-free mice, which in turn, influence the host selenium status and
selenoproteome expression.
Second, we characterized the phenotype of the 15 kDa selenoprotein (Sep15) knockout
(KO) mice. Sep15 is a thioredoxin-like, endoplasmic reticulum (ER)-resident protein involved in
the quality control of glycoprotein folding through its interaction with UDP-glucose:glycoprotein
glucosyltransferase. We found that Sep15 KO mice develop nuclear cataracts at an early age. We

suggest that the cataracts resulted from improper folding status of lens proteins caused by Sep15
deficiency.
Third, we evaluated the role of Se and selenoproteins in naked mole rat (MR)
Heterocephalus glaber, a rodent model of delayed aging due to its unusually long lifespan (>28
years). Tissue imaging by X-ray fluorescence microscopy and direct analyses of trace elements
revealed low levels of selenium in the MR tissues. Metabolic labeling of MR cells with
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Se

followed by sequencing and assembly of the MR transcriptome revealed the loss of expression of
glutathione peroxidase 1 (GPx1), whereas expression of other selenoproteins was preserved.
Thus, MR is characterized by reduced utilization of selenium due to a specific defect in GPx1
expression.
Overall, the use of rodent models allowed us to obtain insights into interplay of dietary
selenium, gut microbiota, and expression and function of several selenoproteins.
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ABBREVIATIONS
APS, advanced Photon Source
CV, conventionalized
Cys, cysteine
DI1, thyroid hormone deiodinase type 1
DI2, thyroid hormone deiodinase type 2
DI3, thyroid hormone deiodinase type 3
ER, endoplasmic reticulum
ERAD, ER associated degradation
ICP-MS, inductively coupled plasma mass spectrometry
GF, germ-free
GPx1, glutathione peroxidase 1
GPx2, glutathione peroxidase 2
GPx3, glutathione peroxidase 3
GPx4, glutathione peroxidase 4
GSH, glutathione
I, iodine
LOCS II, Lens Opacities Classification System version II
MR, naked mole rat (H. glaber)
MsrA, methionine-S-sulfoxide reductase
MsrB, methionine-R-sulfoxide reductase
MEF, mouse embryonic fibroblasts
NMR, nuclear magnetic resonance
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PSA, prostate specific antigen
Se, selenium
Sec, selenocysteine
SECIS, selenocysteine insertion sequence
SelH, selenoprotein H
SelI, selenoprotein I
SelK, selenoprotein K
SelM, selenoprotein M
SelN, selenoprotein N
SelO, selenoprotein O
SelP, selenoprotein P
SelS, selenoprotein S
SelT, selenoprotein T
SelV, selenoprotein V
SelW, selenoprotein W
Sep15, the 15 kDa selenoprotein
SOD, superoxide dismutase
SPS1, selenophosphate synthetase 1
SPS2, selenophosphate synthetase 2
UGT, UDP-glucose:glycoprotein glucosyltransferase
UPR, unfolded protein response
UTR, untranslated region
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CHAPTER 1
Introduction
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1.1 Selenoproteins: Identification and function
The first identified selenoprotein was glutathione peroxidase 1 (GPx1) [1]. Initially
isolated from erythrocytes, it was shown to protect hemoglobin from oxidative damage.
Later, it was found to be highly dependent on selenium, which was incorporated into GPx1
as the 21st amino acid, selenocysteine (Sec) [2, 3]. In comparison to cysteine (Cys), Sec has
a lower pKa and is a stronger nucleophile [4]. Almost all known selenoproteins are
enzymes with Sec in the active center. Sec insertion requires the presence of in-frame TGA
codon and Sec insertion sequence (SECIS) element, a kink-turn RNA structure located in
the 3’ UTRs of selenoprotein mRNAs. Biosynthesis of Sec occurs on its specific tRNA,
tRNASer[Sec], which is initially charged with Ser. SECIS-binding protein 2 (SBP2) binds to
the SECIS element in the RNA and recruits Sec-tRNASer[Sec] along with other factors
involved in Sec insertion [5, 6]. Identification of the structure and conserved sequences of
the SECIS element allowed development of computational programs for identification of
selenoprotein genes in sequence databases [7-9]. The program SECISsearch was designed
to recognize structural and thermodynamic parameters of SECIS elements [10]. By
searching for SECIS elements, the in-frame TGA codon in the ORF and the presence of
Cys orthologs of selenoproteins, it is possible to identify selenoprotein genes in genomic
sequences. The human genome contains 25 selenoprotein genes (Table 1). Most of these
proteins participate in maintaining cellular redox homeostasis, including three thioredoxin
reductases (TRs), five glutathione peroxidases (GPx1), methionine sulfoxide reductase
(MsrB1), and three thyroid hormone deiodinases (DIs).
As is clear from Table 1, few selenoproteins have known functions. Besides TRs,
GPxs, MsrB1, DIs, SelP, SelN and SPS2, the specific reactions catalyzed by selenoproteins
are not known. However, conservation of selenoproteins among species and preservation
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of the complicated biosynthesis pathway for their production indicate importance of this
class of proteins. So far, the common feature of all selenoproteins with identified functions
is their participation in the thiol-dependent reactions. This type of reactions is important in
intracellular redox homeostasis and antioxidant defense. GPxs (and the N-terminal domain
of SelP) are capable of reducing various peroxides [11, 12]. TRs and MsrB1 participate in
the reduction of oxidized cysteine and methionine residues, respectively [13-16]. DIs
catalyze removal of iodine (I) from the outer ring of the prohormone thyroxine (T4)
yielding various forms of thyroid hormone [17, 18]. Sep15, SelM, SelH, SelS, SelN, SelT,
SelW are less characterized, whereas almost studies have been done involving SelV, SelO,
SelI and SelK. Most likely, all these proteins are oxidoreductases with Sec in the active
site. More than half of mammalian selenoproteins are characterized by the thioredoxin like
fold. Thioredoxin-like fold is a two-layer α/β/α sandwich structure that includes a
conserved CXXC motif. In some cases, one of the Cys can be substituted with Ser or Thr.
This fold is common for enzymes that catalyze formation or isomerization of disulfide
bonds. At least 7 out of 25 selenoproteins (DI2, Sep15, SelK, SelM, SelN, SelS, and SelT)
reside in the ER. ER enrichment with selenoproteins might indicate the roles of
selenoproteins in ER associated processes, such as protein secretion/modification or ER
associated degradation ERAD [19].
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Table 1. Mammalian selenoproteins: localization and functions
Selenoprotein
Localization
15 kDa selenoprotein
ER
(Sep15)

Thyroid hormone
deiodinase 1 (DI1)

Thyroid hormone
deiodinase 2 (DI2)
Thyroid
hormone
deiodinase 3 (DI3)

Plasma
membrane

ER
Plasma
membrane

Glutathione
peroxidase 1 (GPx1)
Glutathione
peroxidase 2 (GPx2)

Cytosol

Glutathione
peroxidase 3 (GPx3)

Plasma

Glutathione
peroxidase 4 (GPx4,
PHGPx)

Cytosol
Mitochondria
nucleus (testis
specific)
Cytosol

Glutathione
peroxidase 6 (GPx6)
Selenoprotein H
(SelH)

Selenoprotein I (SelI)
Selenoprotein K
(SelK)
Selenoprotein M
(SelM)
Selenoprotein N

Cytosol

Nucleus

Membrane
ER
ER
ER membrane

Possible function
ReReferences
-Trx-like fold
[20-23]
-regulated by ER stress
-interacts with UDP-glucose:glycoprotein
glucosyltransferase
-potentially involved in glycoprotein
folding
-removes iodine from the outer ring of the [24, 25]
T4 thyroid hormone to produce plasma T3
-catalyzes
deiodination
and
thus
inactivation of T3
-converts T4 to T3 locally in tissues
[26]
-catalyzes deiodination of T4 thyroid [25, 27]
hormone to T3 in peripheral tissues
-GSH dependent detoxification of H2O2
(enriched in liver, kidney, erythrocytes)
-GSH dependent detoxification of H2O2
(enriched in epithelial tissues, including
intestine and lung)
-GSH dependent detoxification of H2O2
(synthetized predominantly in kidneys and
secreted to plasma)
-has cytosolic, nuclear and mitochondrial
isoforms
-protects lipids from H2O2 mediated
oxidation
-GSH dependent detoxification of H2O2
(enriched in the olfactory epithelium)
-Trx-like fold
-protects cells from H2O2, increases
mitochondrial biogenesis and CytC
production
-AT-hook family protein. In response to
redox changes facilitates synthesis of genes
responsible for de novo glutathione
synthesis and phase II detoxification
unknown function
-modulates Ca2+ influx that affects immune
cell function
-Trx-like fold
-protects neurons from oxidative stress
-expressed in skeletal muscle, heart, lung,

[11]
[28, 29]

[30]

[31]

[29]
[32-34]

[10]
[35]
[36]
[19, 37]
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(SelN, SEPN1,
SelN1)

Selenoprotein O
(SelO)
Selenoprotein P
(SelP)
Selenoprotein R
(SelR, MsrB1)
Selenoprotein S
(SelS, SEPS1, Tanis,
VIMP, and
SELENOS)
SPS2
Selenoprotein T
(SelT)

Mitochondria
Plasma
Cytosol
ER

Cytosol
ER and Golgi

Thioredoxin
reductase 1 (TR1)

Cytosol

Thioredoxin
reductase 2 (TR2,
TGR)

Cytosol

Thioredoxin
reductase 3 (TR3)
Selenoprotein V
(SelV)

Mitochondria

Selenoprotein W
(SelW)

Cytosol

Cytosol

and placenta
-controls redox state of the intracellular
calcium-release channel (ryanodine
receptor (RyR)), and therefore affects Ca2+
homeostasis
-mutations in SelN gene cause congenital
myopathy
unknown function
-Se transport to peripheral tissues and
antioxidant function
-reduces methionine-R-sulfoxide residues
in proteins to methionine
-upregulated upon treatment with proinflammatory cytokines and glucose
deprivation
-co-purifies with the ERAD complex
-synthesis of selenophosphate
-Trx-like fold
-redox regulation
-plays a role in cell adhesion
-controls redox state of thioredoxin
-has 6 isoforms generated by alternative
splicing
-contains glutaredoxin domain
-catalyze a variety of reactions, specific for
thioredoxin and glutaredoxin systems
-expressed in spermatids
-reduces mitochondrial thioredoxin and
glutaredoxin 2
-Trx-like fold
-unknown function
-expressed in spermatids
-Trx-like fold
-unknown function
-expressed in skeletal muscles

[10]
[38-40]
[16]
[19, 41]

[42, 43]
[44]

[13, 45]

[46]

[47]
[32]

[48]
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1.2 Mouse models for studying selenoproteins
Knockout (KO) and transgenic models can be used for evaluating protein functions
as well as their impact on health. To evaluate selenoprotein functions, a number of mouse
models were developed and characterized. Generally, all models can be divided into two
groups. The first group includes animals lacking (or overexpressing) one or more
individual selenoproteins. The second group includes various mouse models with altered
selenoprotein biosynthesis pathway. These animals develop systemic selenoprotein
deficiency. Both groups are discussed in the following sections.
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1.2.1 Targeted removal of individual selenoproteins
Several mouse models with targeted inactivation of one or more selenoproteins were
developed and characterized [49, 50]. The overview is given in Table 2. So far, three
selenoproteins were found to be essential: TR1, TR3 and GPx4. Knockout of cytosolic TR1 leads
to embryonic death between E8.5 and E10.5 [51]. While the cardiomyocyte-specific TR1 KO mice
developed normally, the neuronal system (NS) specific TR1 knockout caused severe neurological
symptoms, such as ataxia and tremor [52]. These symptoms were the result of cerebellar
hypoplasia, abnormal foliation, perturbed lamination in the cerebellum and reduced
proliferation of granule cell precursors in cerebellum [52]. Disruption of TR1 in B and T cells did
not affect viability and functions of immune cells [53]. Mitochondrial TR3 knockout induced
embryonic lethality between E13.5 and E15.5. Compared to controls, embryos were smaller,
developed anemia and showed high levels of liver apoptosis. NS-specific TR3 KO mice developed
normally, without signs of neurodegeneration; however, the cardiomyocyte-specific TR3 KO
mice died from heart failure within few hours of birth [54].
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GPx4 is another essential enzyme: KO of this gene leads to embryonic lethality at E7.5
[55]. GPx4 has cytosolic (cGPx4), nuclear (nGPx4) and mitochondrial (mGPx4) isoforms. All
isoforms are synthesized from alternative translation initiation codons. nGPx4 expression is
driven by its own testes-specific promoter, which lies inside the first intron of the cytosolic GPx4
transcript [31]. To access the function of each isoform, several KO/transgenic mouse models
were obtained. nGPx4 KO mice developed normally; neither testicular structure nor fertility
were affected in these mice; however the delayed sperm chromatin condensation was observed
[56]. The sequence between the two alternative translational initiation codons encodes a
mitochondrial signal peptide. Thus, introduction of the in-frame stop codon between alternative
translation initiation codons resulted in the disruption of the mGPx4 form without affecting
expression of cGPx4. mGPx4 KO male mice were infertile [57]. These experiments revealed an
essential role of mGPx4 in male fertility.
KO of other GPxs did not affect viability and fertility. The major findings with GPx KO
mice are summarized in Table 2. GPx1 KO mice did not show significant phenotypes; however,
they were more susceptible to oxidative stress and viral myocardites [11, 58]. GPx2 is mainly
expressed in epithelial tissues, and its disruption affects intestinal cells [59]. Double GPx1 and
GPx2 KO mice are characterized by severe colitis when maintained on an atherogenic diet [60].
Recently, GPx3 KO mice were developed [61]. Even though no significant phenotype was
observed, this model revealed the specific binding of GPx3 to the basement membranes of renal
cortical proximal and distal convoluted tubules.

Experiments designed to understand the function of selenoproteins in thyroid gave
ambiguous results. Both general and liver-specific knockout of DI1, which is mainly
expressed in thyroid and responsible for plasma T3 supply, did not lead to hypothyroidism,
indicating a possible additional function in T3 degradation [62, 63]. DI2 is expressed in the
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pituitary and is thought to be a T4 sensor that decreases TSH production, being part of the
negative feedback loop for thyroid hormone production. DI2 KO mice showed pituitary
resistance to T4 [64]. DI2 turned out to be important in conversion of T4 to T3 in
peripheral tissues. T3 stimulation is critical for the development of the auditory functions
[26, 65]. Lack of DI2 resulted in delayed cochlear differentiation that was the reason for
the irreversible deafness of DI2 KO mice [65]. DI1/DI2 KO mice did not augment the
phenotype of D1 or D2 KO mice; it was rather the sum of each single KO [66]. DI3 is
responsible for inactivation of T3. DI3 KO mice showed mild hypothyroidism, suggesting
importance of T3 degradation for maintaining the thyroid hormone axis [67]. D3 KO mice,
like DI2 KO mice, were characterized by impaired auditory function, but with different
pathogenesis. Unlike DI2 KO, DI3 KO mice displayed accelerated cochlear differentiation,
which also resulted in deafness. This finding suggests a protecting role of DI3 in cochlear
development [68].
Experiments with SelP KO mice suggested that the major function of SelP is the
transport of Se from liver to peripheral tissues [69, 70]. SelP KO mice developed
symptoms of general Se deficiency, such as ataxia, seizures and male infertility [71, 72].
Some of these symptoms could be rescued by dietary Se. Apparently, SelP KO mice is a
particularly well suited model to study Se deficiency. The majority of SelP is synthesized
in the liver. Analysis of the liver-specific Sec tRNASer[Sec] KO (liver Trsp KO) mice (these
mice lack expression of all selenoproteins in the liver and will be discussed later in this
chapter) showed decreased expression and activity of selenoproteins in peripheral tissues,
which confirmed the transport function for the hepatic SelP [73]. The levels of Se in the
brain remained unaffected in liver Trsp KO mice; also, these mice did not show any
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neurological phenotype. These findings suggested another essential SelP function in the
brain. Restoration of liver SelP expression in SelP KO mice restored Se transport and
removed symptoms associated with Se deficiency [74]. Thus, hepatocyte-derived SelP
provides the major Se supply for kidneys, testes and brain. However, under Se deficiency,
overexpression of liver SelP was unable to rescue the phenotype of SelP KO mice, which
indicates the importance of local SelP production to support selenoprotein biosynthesis
under limiting Se conditions [74]. SelP consists of two parts. The N-terminal domain
contains a conserved UxxC motif, which is part of the domain characterized by the
thioredoxin-like fold [38]. The C-terminal part of SelP contains multiple Sec residues and
is involved in providing Se for synthesis of other selenoproteins. Deletion of the Cterminal region of SelP resulted in a milder phenotype compared to the KO of the entire
protein. Overall, the C-terminus plays a critical role in Se transport [75].
Recently, two additional KO models were described [76]. A KO of MsrB1 did not
lead to strong phenotypes: the KO mice were viable and fertile. However, various tissues
of MsrB1 KO mice were characterized by a decreased level of MsrA (methionine sulfoxide
reductase specific for Met-SO) and increased levels of malondialdehyde, protein carbonyls,
protein methionine sulfoxide, as well as higher levels of oxidized glutathione and reduced
levels of free and protein thiols; all this indicates the persistent oxidative stress in MsrB1
KO mice.
Inactivation of the SelK gene also did not affect viability and fertility [35].
However, as a result of the receptor mediated Ca2+ flux, SelK KO mice showed
compormised functions of the immune cells, including T cell proliferation, T cell and
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neutrophil migration, and Fcγ receptor-mediated oxidative burst in macrophages, as well as
higher susceptibility to viral infection.
There are a number of selenoproteins, which are still poorly characterized, and
which would benefit from developing of knockout mouse models. This list includes SPS2,
SelI, SelO, SelS, SelT, SelV, SelW, and GPx6.
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Table 2. Knockout of individual selenoprotein genes in mice
Gene
GPx1

GPx2

GPx1+GPx2
GPx3
GPx4
TR1
TR3
DI1
DI2

DI3

DI1+DI2
SelP

MsrB1
SelK

Phenotype
-no gross phenotypes
-susceptibility to oxidative stress and viral miocardites
-acceleration of cardiac hypertrophy and dysfunction
-reduced blood insulin and reduced islet β-cell mass in
pancreatic tissue
-no gross phenotypes
-increased apoptosis in colon crypt cells during Se
deficiency
-microflora-dependent intestinal colitis
-decreased levels of Paneth cells
-no gross phenotypes
-embryos die at E7.5
-embryos die at between E8.5 and E10.5
-embryos die at between E13.5 and E15.5
-no gross phenotypes
-increased iodine excretion
-pituitary resistance to T4
-impaired thermogenic response to cold
-at thermoneutral conditions, high fat diet induced glucose
intolerance, and exacerbated hepatic steatosis
-poor hearing, poorly differentiated sensory epithelium
-reduced levels of circulating T4 and T3
-retarded development
-deafness with premature cochlear differentiation
-mild hypothyroidism
-the sum of DI1 KO and DI2 KO phenotypes
-neuronal degeneration, leading to ataxia and seizures
-reduced selenoprotein expression in peripheral tissues
-male infertility
-no gross phenotypes
-increased markers of oxidative stress
-no gross phenotypes
-impaired functions of immune cells
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1.2.2 Overexpression of selenoproteins in mice

Besides selenoprotein gene KO, several studies described animals with
overexpression of individual selenoproteins. One of the best such models is GPxoverexpressing mouse (GPx1oe). These mice were shown to develop hyperglycemia and
hyperinsulinemia, and developed high levels of blood insulin and increased islet β-cell
mass [77-79]. It should be noted that similar symptoms are observed in Type 2 diabetes.
When maintained on high fat diet, these mice developed obesity and insulin resistance,
unlike GPx1 KO mice, which had reduced insulin levels and decreased islet β-cell mass
[78]. This phenotype of GPx1oe mice might be explained by insufficient ROS-mediated
signaling in islet β-cells. In a different model of diabetes, expression of GPx1 had a
beneficial effect. Here, overexpression of GPx1 in islet β-cell of the db/db mice alleviated
hyperglycemia at an early age and completely reversed it by 20 weeks of age [80]. These
results indicate the importance of controlled GPx1 expression for prevention of Type 2
diabetes.
Another group developed mice with transgenic overexpression of mitochondrial
GPx4 (mGPx4) [81]. Compared to littermate controls, these mice developed attenuated
cardiac dysfunction in response to ischemia/reperfusion injury. Overexpression of mGPx1
reduced the levels of lipid peroxidation and slightly increased the activity of the electron
transport chain (ETC) complexes I, III, and IV.
Another example of overexpression of a selenoprotein in an animal model is
overexpression of SelM in rats [82]. These rats showed a better response to oxidant
treatment. When fed with high Se diet, transgenic rats showed altered ERK signal
transduction in the brain, which was characterized by inhibition of the alpha/gamma-
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secretase activity and Tau protein phosphorylation. These observations suggest a possible
protective role of SelM in Alzheimer's disease [83].

1.3 Mouse models targeteing the selenoprotein biosynthesis
pathway
Inactivating a single selenoprotein in mouse can provide information about its
function and phenotypes associated with its deficiency. However, targeting the Sec
incorporation machinery allows modulation of expression of all selenoproteins. Many such
models have been developed.
1.3.1 Selenocysteine incorporating machinery

In eukaryotic cells, Se incorporation is a complex multi-stage process [5, 6, 84, 85].
The overall pathway of Sec incorporation is illustrated in Fig 1. Sec is synthesized on its
own tRNA, tRNA[Ser]Sec, which is the product of the Trsp gene. Initially, this tRNA is
charged with Ser, forming Ser-tRNA[Ser]Sec. This reaction is catalyzed by seryl-tRNA
synthetase (SerRS). Ser-tRNA[Ser]Sec

is further phosphorylated by phosphoseryl-

tRNA[Ser]Sec kinase (PSTK). The Se donor compound for the Sec biosynthesis,
selenophosphate, is synthesized by selenophosphate synthetase 2 (SPS2). O-PhosphoseryltRNA:selenocysteinyl-tRNA synthase (SecS) catalyze the pyridoxal phosphate dependent
reaction which is resulted in Sec-tRNA[Ser]Sec formation. After that Sec-tRNA[Ser]Sec EFSec
and SBP2 protein factors, and this supramolecular complex is translocated to nucleus [86].
SBP2 recognizes the SECIS element, which is located in the 3’-UTR of selenoproteins
mRNAs. This complex supports the incorporation of Sec in response to the in-frame-UGA
codon. There are several features, which are critical for proper function of the pathway: 1)
As shown in Fig 1, SBP2 and EFSec shuttle between the nucleus and cytosol. This allows
binding selenoprotein mRNAs in the nucleus and inhibition of the nonsense mediated
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decay induced by in-frame stop codon [87]. 2) SPS2 is itself a selenoprotein, forming a
positive feedback loop with the Se available in the cell [42]. 3) Recently, it was found that
SPS2 can also synthesize thiophosphate, promoting incorporation of Cys in place of Sec.
In mice maintained on the Se-deficient diet, insertion of Cys at UGA codon of TR1
equaled that of Sec [88]. 4) Sec tRNA[Ser]Sec is a unique tRNA which undergoes multiple
modifications, further regulating Sec incorporation. These modifications include
isopentyladenosine modification at position 37 and methylcarboxymethyl-5’-uridine
(mcm5U) at position 34. The last step in Sec tRNA[Ser]Sec maturation is the methylation of
mcm5U, which is assisted by Secp43 and results in the formation of methylcarboxymethyl5’-uridine -2’-O-hydroxymethylribose (mcm5Um) [89]. This process is highly sensitive to
the primary, secondary and tertiary structure of tRNA as well as to the overall Se status.
mcm5U supports synthesis of “housekeeping” selenoproteins, such as GPx4, TR1 and TR3
, whereas the methylated tRNA is needed for expression of “stress-related”
selenoproteins, such as GPx1, GPx3, and MsrB1. This change in selenoproteins expression
pattern is commonly observed during Se deficiency, but the precise molecular mechanism
is unknown.
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Figure 1. Schematic model for Sec biosynthesis and incorporation. See details in
the text. Sec tRNA[Ser]Sec is charged with Ser, which is further phosphorylated by PSTK SPS2
facilitate synthesis of the selenophosphate. SecS catalyze Sec formation. SECp43 catalyze
methylation of the Sec tRNA[Ser]Sec at the A34 position. Protein factors, including SBP2 and
EFSec binds to the SECIS element, located in the 3’UTR of the selenoprotein mRNA. After
translocation to the cytosol protein factors facilitate interaction with the ribosome and Sec
incorpotation.1.3.2 Mouse models targeting the selenoprotein biosynthesis pathway
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There are several ways to regulate efficiency of Sec incorporation. In order to
modulate expression of selenoproteins, the easiest way is to change levels of dietary Se. To
examine the effects of dietary Se on various health parameters, one can adjust Se
concentration in rodent chow. For example, 0.1 ppm Se in rodent diet approximately
corresponds to the human Recommended Dietary Allowance for adults, whereas 0.4 ppm
Se may correspond to the diet supplemented with 200 µg Se/day, which is the dose most
often used in the clinical trials involving Se [90-92]. This approach was successfully
applied to examine Se function in diabetes [93], cancer [94], the immune response [95, 96],
etc. The disadvantage of this approach is that, with change in dietary Se, the levels of low
molecular weight Se compounds are also changed, which might itself influence certain
pathways.
1.3.3 Trsp transgenic models

Stable expression of mutant Trsp was shown to severely affect selenoprotein
biosynthesis by interfering with the Sec incorporation pathway by a dominant-negative
mechanism. According to this hypothesis, two mouse models were generated. In the first
model, A37 was substituted with G37 [97], and in the second, T34 was replaced with A34
[98]. Both models lacked Um34; thus, expression of stress related selenoproteins was
severely reduced, whereas expression of housekeeping selenoprotein genes was little
affected. The effect of G37 transgene was tissue-specific: it was significant in liver and
kidney, but low in tissues testes [97]. The G37 transgenic mice were studied for various
health parameters. These mice were found to be more susceptible to viral infection [99],
colon cancer [100] and X-ray damage [101]. Crossing of the G37 and C3/Tag mice
provided a good model for studying the function of selenoproteins in prostate cancer. Such
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mice were found to accelerate the development of prostatic epithelial neoplasia (PIN),
suggesting a protecting role of selenoproteins during prostate cancer development [102].
G37 mice demonstrated enhanced muscles growth in experiments modeling the exercise
overload. . These data correlated with initial activation of the insulin signaling pathway,
which includes increased Akt and p70 phosphorylation [103]. Abnormal insulin signaling
might be, in part, the reason for glucose intolerance and lead to a diabetes-like phenotype,
that had been recently observed in G37 mice [93].
1.3.4 Mouse models of Trsp knockout

Another approach of inactivating selenoprotein function in mice is to target the
Trsp gene. The complete KO of Trsp leads to embryonic lethality, but a conditional
removal of Trsp is possible [104]. Development of the tissue-specific KO models helped to
examine important functions of selenoproteins in heart and skeletal muscles, endothelial
cells [105], skin [106], bone [107], neurons [106] and immune cells (macrophages, T cells
and hematopoietic tissues) [108-110], but also more dispensable selenoprotein functions in
liver [73, 111], mammary gland [104] and podocytes [112]. KO of Trsp in endothelial cells
led to embryonic death at E14.5 due to necrosis of the central nervous system, erythrocyte
immaturity and subcutaneous hemorrhage. Mice with the myocyte-specific Trsp KO died
12 days after birth from acute myocardial failure [105]. Deletion of Trsp in skin resulted in
runt phenotype, epidermal neoplasia, and abnormal development of the hair follicles.
Altogether, these abnormalities induced weight loss and early death. Thus, selenoproteins
have a function in maintenance of skin integrity [106]. Osteo-chondroprogenitor-specific
Trsp KO mice showed multiple skeletal abnormalities, including growth retardation,
abnormal epiphyseal plates, delayed ossification, and chondronecrosis of cartilage [107].
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The neuron-specific Trsp KO induced severe neurodegeneration in hippocampus and lead
to the absence of certain interneurons [106] (similar to that that observed in the neuronspecific GPx4 KO model). Besides, these mice showed degeneration of the Purkinje and
granule cells that lead to cerebral hyperplasia. In several studies, Se modulated the immune
response. To understand the function of selenoproteins in immune cells, T and B cellspecific Trsp KO mice were developed. The T-cell-specific Trsp KO had decreased pool of
mature T-cells and impaired T-cell dependent antibody response. Lack of antioxidant
enzymes caused extensive oxidative stress and weak proliferation in response to T-cell
receptor stimulation [109]. Macrophage specific-Trsp KO mice showed impaired
invasiveness, which might be explained by hyperproduction of ROS and altered expression
of extracellular matrix proteins [108]. Ablation of the Trsp gene in hematopoietic tissues
resulted in anemia, which led to an increased production of erythroid progenitors in bone
marrow as well as to thymus atrophy [110]. The liver-specific Trsp KO induced expression
of phase II enzymes, including various GSTs [113]. By preventing SelP synthesis and
secretion, the liver-specific Trsp KO dramatically decreased plasma SelP. Thus, these mice
showed symptoms of Se deficiency, which could be rescued by increased Se intake.
Further characterization of these mice revealed elevated levels of apolipoprotein E (ApoE)
in serum as well as plasma cholesterol [98]. The mammary gland-specific Trsp KO mice
showed increased levels of p53 and decreased expression of BRCA1 tumor suppressor
[104]. Overall, mouse models with conditional Trsp KO turned out to be a powerful tool
for understanding functions of selenoproteins in tissues.
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1.3.5 Knockout/transgenic mouse models

An additional strategy to investigate the effect of transgene overexpression is to
develop KO/transgenic animal models. In the case of selenoproteins, liver Trsp KO mice
were crossed with G37 or A34 mice. In both cases, similar expression pattern of
housekeeping selenoproteins was observed. Restoration of the housekeeping selenoprotein
genes partially decreased elevated levels of ApoE and serum cholesterol that had been
observed in the liver-specific Trsp KO. This research directly revealed the function of
housekeeping selenoproteins in regulation of lipoprotein biosynthesis and metabolism [98].
Another knockout/transgene mouse model was described in [114]. STAF (Sec
tRNA gene transcription activating factor) is a transcription factor for several RNA PolII
and RNA PolIII-dependent genes. In this study, the authors overexpressed Trsp lacking the
STAF binding promoter region and afterwards removed the WT Trsp. Interestingly,
removal of the STAF binding site did not affect Trsp levels in heart and testis, but showed
severe reduction of the transgene in liver, kidney, lung, spleen, and brain. Moreover,
methylation of Trsp at A34 was significantly decreased, and expression of stress-related
selenoproteins was reduced. These mice demonstrated the neurological phenotype similar
to that of SelP KO mice. These findings indicated the importance of the STAF binding
region in regulation of Sec tRNASer[Sec] expression and its proper modification.
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CHAPTER 2
Dietary selenium affects host selenoproteome expression by influencing the gut
microbiota

Note: The results described in this chapter have been published.
Kasaikina, M.V., Kravtsova, M.A., Lee, B.C., Seravalli, J., Peterson, D.A., Walter,
J., Legge, R., Benson, A.K., Hatfield, D.L. & Gladyshev, V.N. (2011) "Dietary selenium
affects host selenoproteome expression by influencing the gut microbiota", The FASEB
journal, in press.

30

2.1 Abstract
Colonization of the gastrointestinal tract and composition of the microbiota may be
influenced by components of the diet, including trace elements. To understand how
selenium regulates the intestinal microflora, we used high-throughput sequencing to
examine the composition of gut microbiota of mice maintained on selenium-deficient,
selenium-sufficient, and selenium-enriched diets. The microbiota diversity increased as a
result of selenium in the diet. Specific phylotypes showed differential effects of selenium,
even within a genus, implying that selenium had unique effects across microbial taxa.
Conventionalized germ-free mice subjected to selenium diets gave similar results and
showed an increased diversity of the bacterial population in animals fed with higher levels
of selenium. Germ-free mice fed selenium diets modified their selenoproteome expression
similar to control mice but showed higher levels and activity of GPx1 and MsrB1 in the
liver, suggesting partial sequestration of selenium by the gut microorganisms, limiting its
availability for the host. These changes in the selenium status were independent of the
levels of other trace elements. The data show that dietary selenium affects both
composition of the intestinal microflora and colonization of the gastrointestinal tract,
which, in turn, influence the host selenium status and selenoproteome expression.

2.2 Introduction
Intestinal microorganisms play an important role in human physiology by
regulating such processes as maturation and proliferation of the intestinal cells, food
digestion, protection from pathogenic bacteria, and modulation of the mucosal immune
response [115, 116]. Growing evidence also links imbalances in the composition of the gut
microbiota to complex diseases, including colon cancer, obesity, inflammatory bowel
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disease, and Crohn’s disease [117-122], suggesting that dietary interventions affecting the
gut microbiota hold substantial promise as alternative approaches to influence human
health [123]. One of the main strategies to regulate the gut microbiota through diet is the
use of prebiotics, which are defined as nondigestible food ingredients that beneficially
affect the host by selectively stimulating the growth and/or activity of one or a limited
number of bacterial species in the colon [124]. Because prebiotics promote growth of a
select group of microorganisms, other strategies must also be examined, including those
that can selectively inhibit or promote growth of species associated with complex diseases.
One such strategy may involve modulation of dietary trace elements. Gut
microorganisms, like their hosts, are expected to be sensitive to trace elements. Some
species require trace elements such as Se for normal metabolic functions, whereas these
same elements can be toxic to other microorganisms, even at very low concentrations [125,
126]. Therefore, changes in dietary trace elements may modulate the composition of
intestinal microbiota. For example, reducing dietary iron (Fe) caused an increase in the
growth of certain organisms in the small intestine, including anaerobes, microaerophiles,
lactobacilli, and enterococci. On the other hand, an increase in dietary Fe suppressed
anaerobes, presumably due to elevated oxidative stress [127]. However, the effect of other
trace elements on intestinal microbiome is largely unknown. Se is an essential trace
element that plays an important role in human health. In particular, it is required for
biosynthesis of selenoproteins, which participate in the regulation of cellular redox
homeostasis, protection from oxidative stress, immune response, cancer chemoprevention,
and other processes [128]. Supplemental Se has been shown to be effective in decreasing
incidence and mortality from several forms of cancer, including colon cancer, in both
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mouse models and humans [100]. On the other hand, some selenoproteins may promote
carcinogenesis, so the role of Se in cancer development is complex.
We hypothesized that Se supplementation may modify composition of mouse
microbiota. At the same time, microflora may sequester Se, thus limiting its availability to
the host [129]. A better understanding of these interactions might reveal novel aspects of
the influence of the microbiota on metabolism of the host. The purpose of the current study
was to characterize the impact of Se diets on microbiota and the role of microbiota in
influencing Se status of the host.

2.3 Experimental Procedures
Animals and feeding protocols. The diets used in the study, including 0-, 0.1-,
0.4-, and 2.25-µg/g (ppm) Se diets, were purchased from Harland TekLad (Madison, WI,
USA). As described previously [94], these diets are based on the Torula yeast Se-deficient
diet. Se was provided in the form of sodium selenite; 0, 0.1, 0.4, and 2.25 ppm Se indicate
the added amounts of Se. In the first experiment, 4-wk-old C57BL/6J male mice
(purchased from Jackson Laboratory, Bar Harbor, ME, USA) were subjected to these 4 Se
diets (8 mice/group). Ten weeks later, feces were collected and frozen until further
analysis. In the second experiment, 10-wk-old germ-free Swiss Webster male mice were
subjected to 3 diets: 0, 0.1, and 0.4 ppm Se. One cohort of these animals (5 mice/group)
was maintained germ free, and these mice are designated germ-free (GF) mice. Another
group (5 mice/group) was placed in a similar germ-free environment, but it was
conventionalized with the microflora prepared from the intestine of C57BL/6J mice used
in the previous experiment. These mice are designated as conventionalized (CV) mice.
Both groups of animals were maintained on the same Se diets, in the same facility and at
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the same time, under specific pathogen-free conditions with 12-h light-dark cycle. All
animal experiments were approved by the University of Nebraska–Lincoln (UNL)
Institutional Animal Care and Use Committee.
Sample preparation. After 8 wk on the diets, feces from CV mice were collected
and frozen until further analysis. Then, GF and CV mice were sacrificed; their tissues were
collected and immediately frozen in liquid nitrogen. For Western blot analysis and activity
measurements, tissues were homogenized in PBS supplemented with protease inhibitor
cocktail (Sigma, St. Louis, MO, USA). Cellular debris was removed by centrifugation
at13,000 rpm for 15 min at 4°C, and protein concentration was determined with the
Bradford assay.
DNA isolation and pyrosequencing. Total DNA was extracted from the fecal
pellets of 8 mice/feeding group, as described previously [130]. The 16S rRNA gene was
amplified using modified F8 and R357 universal primers. These 16S rRNA PCR products
were then subjected to pyrosequencing on a Roche/454 GS-FLX instrument (Roche, Basel,
Switzerland) in the UNL Core for Applied Genomics and Ecology. The PCR products
from each animal were bar coded and then mixed into a single sequencing run on the
machine, so as to generate 2000 reads/animal. Taxonomy-dependent analysis was first
performed using the naive bayesian Classifier algorithm of the Ribosomal Database Project
(RDP; Michigan State University, East Lansing, MI, USA). Phylotypes were determined at
97% cutoffs using CD-Hit, and representative sequences were searched against the RDP
database using SeqMatch. Statistical analyses were performed on taxonomic groups from
Classifier and CD-Hit phylotypes by normalizing the number of reads per taxon or
phylotype by the total number of reads for a given animal. These normalized proportions
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were then tested for statistical significance by ANOVA. For rarefaction analysis,
phylotypes were assigned using the RDP pipeline (Aligner complete linkage clustering)
and rarified using the Web-based rarefaction tools.
Western blot analyses and activity assays. Expression of selenoproteins GPx1,
SelP and MsrB1 was analyzed by Western blots with polyclonal antibodies specific for
these proteins. To assay for GPx1 activity, a glutathione peroxidase kit was used (Sigma).
MsrB activity was measured in an HPLC assay. Briefly, 200 µg of total protein was added
to a reaction mixture (100 µl), the mixture was kept at 37°C for 30 min in the presence of
20 mM DTT, and 200 µM dabsyl-methionine-R-sulfoxide was added. After stopping the
reaction by adding 200 µl acetonitrile, it was centrifuged at 4°C for 15 min at 13,000 rpm,
and the supernatant (50 µl) was injected onto a C18 column (Zorbax Eclipse XDB-C18;
Agilent Technologies, Santa Clara, CA, USA) to quantify the resulting dabsylated
methionine.
RNA isolation and quantitative PCR. To analyze for SelP mRNA expression in
the liver, total RNA was isolated by TriZOL extraction (Invitrogen, Carlsbad, CA, USA),
according to the manufacturer’s instructions. Genomic DNA was removed using a DNA
removal kit (Ambion, Austin, TX, USA). RNA concentration was measured
spectrophotometrically, and cDNA was obtained with SuperScript III Reverse
Transcriptase (Invitrogen). Real time PCR was performed using a Fast SYBR Green
Master Mix (Applied Biosystems, Foster City, CA, USA). Primer sequences for the SelP
expression

analysis

were

as

CCTTGGTTTGCCTTACTCCTTCC-3’

described
and

previously

[131]:

5’-

5’-TTGTTGTGGTGTTTGTGGTGG-3’.

SelP mRNA expression level was normalized to that of actin mRNA.
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Analyses of trace elements. To measure Se content in biological materials, we
applied quantitative inductively coupled plasma mass spectroscopy (ICP-MS). Tissue
extracts were digested with the mixture of 15% nitric acid and 15% hydrogen peroxide for
2 h at 70°C. After digestion, samples were diluted 10x with PBS, and the internal standard
(gallium) was added to a final concentration of 50 ppb. Each sample was analyzed 3 times
and in triplicate. The ICP-MS analysis was performed at the UNL Redox Biology Center
spectroscopy core facility, using 7500 Agilent Technologies and Elemental Scientific
(Omaha, NE, USA) SC4 autosampler instruments operating with a collision.

2.4 Results
Dietary Se regulates composition of the intestinal microbiota. To assess the
effect of dietary Se on the composition of mouse microbiota, 2-mo-old male C57BL/6J
mice were subjected to a Se-deficient diet and diets supplemented with 0.1, 0.4, or 2.25
ppm of Se in the form of sodium selenite. Previously, these diets were shown to modulate
selenoprotein expression [94]. The expected (i.e., based on what is known about regulation
of selenoprotein expression) changes in selenoprotein levels are shown schematically in
Fig 2A. After 8 wk on the diets, the Se status of mice was examined by analyzing the
levels of SelP, the main selenoprotein in plasma of mammals. SelP decreased dramatically
in mice fed the Se-deficient diet, whereas, as expected, the differences in SelP levels
among mice fed other diets were minimal (Fig 2B). Feces from animals in the Se diet
groups were collected, and the gut microbiota were examined by pyrosequencing of 16S
ribosomal RNA tags at a sequencing depth of ~2000 reads/animal. Using a threshold of
97% for phylotype assignment, rarefaction analysis of the data pooled by Se diet group
showed a significant effect of Se deficiency on the numbers of phylotypes that were
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detected. Overall, Se in the diet increased the diversity of the microbiota (Fig 3A). This Seinduced increase was similar at all supplementation levels. To examine the effects of Se on
major taxonomic groups of the microbiota, the proportions of taxa at the phylum, class,
and order level from Classifier data were analyzed by ANOVA. No significant differences
were observed on the relative proportions of major taxonomic groups (data not shown).
The effects on specific phylotypes were then examined using 97% CD-Hit clusters.
ANOVA identified several phylotypes showing significant effects of diet (Fig 3B).
Remarkably, there were differential effects on related taxa. For example, some phylotypes
belonging to the class Bacteriodales showed increases in response to Se (e.g.,
Porphyromonadaceae phylotypes 1 and 3, Tanerella phylotype 2), whereas others, such as
Alistipes phylotype 1 and Parabacteroides phylotype 3 declined. Relative to absolute
abundance, the decline in Parabacteroides in response to Se in the diet was by far the most
significant effect on the microbiota. As with many phylotypes in the Bacteriodetes, several
of the Firmicutes also showed modest effects in response to Se, including phylotypes
within the Clostridia and Erysipelotrichi.
Se supplementation influences bacterial colonization of the gastrointestinal
tract. To determine whether the microbiota have a significant effect on the physiological
distribution of dietary Se, GF Swiss Webster mice were treated with the same 3 Se diets (0,
0.1, and 0.4 ppm Se), except that these diets were sterilized. One cohort of these animals
was maintained GF, while the gut microbiota was reestablished in the other cohort using
fecal materials from the CV C57BL/6J animals used in the previous experiment. Before
and after 8 wk of diet treatment and conventionalization, SelP levels were examined in
plasma, and fecal samples were taken at the end of the experiment and subjected to the
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analysis of microbiota. Western blots revealed undetectable SelP in all mice fed the Sedeficient diet, whereas little difference was observed between the 0.1- and 0.4-ppm Se
groups (Fig 2C). Thus, dietary Se affects selenoprotein expression independent of GF, CV,
or colonization conditions in mice. Similar to the conventional animals, pyrosequencing of
the microbiota from conventionalized GF animals showed effects on the microbiota. Most
notable was an increase in the overall diversity of the microbiota (Fig 3A). While the 0.4ppm diet in the conventionalized GF animals showed significantly increased diversity, the
0.1-ppm diet did not. Statistical analysis of the phylotype abundances in the
conventionalized GF animals showed that several phylotypes were affected by dietary Se
(Fig 3B). In general, these phyla belonged to the same taxonomic groups as those affected
in

the

conventional

animals,

including

phylotypes

related

to

Tanerella

and

Porphyromonadaceae. As in the conventional animals, these phylotypes showed
differential effects, with some being stimulated by Se and others significantly decreasing.
Likewise, one of the phylotypes belonging to the Clostridiales showed significant increases
in response to Se in the conventional animals, but another phylotype was significantly
reduced in response to dietary Se in the conventionalized GF animals. Collectively, our
results show that dietary Se affects the overall diversity of the microbiota and has
differential effects on specific taxonomic groups, even in related taxa. These effects were
observed whether the microbiota was obtained naturally or by conventionalizing GF
animals.
Microbial colonization affects the levels and activities of selenoproteins of the
host. Gastrointestinal microbiota was recently shown to affect Se status and selenoprotein
expression in mice [129]. In that study, conventional FVN/NHanTMHsd maintained for 5
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weeks on Se-deficient and Se-adequate diets showed reduced GPx and/or thioredoxin
reductase 1 (TR1) activities in plasma, liver, and/or intestine under Se limiting conditions,
when compared to the corresponding GF group. In our study, we analyzed the status of
stress-related selenoproteins, GPx1 and MsrB1, in tissues of GF mice in comparison with
those in CV mice, which served as controls, thus allowing us to directly examine the effect
of gut colonization on the selenoprotein status of animals. In this experiment, GF and CV
mice were subjected, in parallel, to 0-, 0.1-, and 0.4-ppm Se diets, and expression levels
and activities of GPx1 and MsrB1 were analyzed in liver and kidney. Both GF and CV
mice showed similar patterns of selenoprotein regulation. Their expression in mice on the
0-ppm Se diet was dramatically lower, and we also observed differences in selenoprotein
expression between 0.1- and 0.4-ppm Se diets. Selenoenzyme activities paralleled the
expression patterns. Total GPx activity (GPx1 is the main GPx in liver and kidney of mice;
thus, this activity largely corresponds to the activity of GPx1), and the total MsrB activity
(MsrB1 is the main MsrB in liver and kidney) was decreased several fold in the 0-ppm Se
group compared to the 0.1-ppm Se group, whereas the 0.4-ppm Se group showed a
statistically significant increase over the 0.1-ppm Se group. This is consistent with the
previous findings that expression of GPx1 and MsrB1 is maximized at ~0.15 ppm Se in the
diet [131]. However, we were particularly interested in the effect of gut colonization on the
regulation of selenoprotein expression (Fig 4). Indeed, within the 0.1-ppm Se groups, we
observed higher GPx1 expression in liver and kidney, and higher GPx activity in kidneys
of GF mice, compared to CV mice. In addition, within the 0.4-ppm Se groups, higher
GPx1 expression and activity were observed in kidneys, and we also found higher MsrB
activity in liver and kidneys of GF mice. In the 0-ppm Se group, we did not observe
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differences between GF and conventionalized mice, probably because of low expression
and activity of selenoproteins, which approached background levels. Overall, there was a
clear pattern wherein conventionalization of mice decreased expression and activity of
stress-related selenoproteins in liver and kidney.
Gut colonization and SelP levels in plasma. Mouse SelP contains 10
selenocysteine residues and is highly expressed in hepatocytes. This secreted protein
transports Se from liver to other organs and was also suggested to serve an antioxidant
function [38]. Unlike other selenoproteins, SelP showed a trend toward increased levels in
CV mice; at least in the mice fed 0.1 ppm Se, as examined by Western blots (Fig 5A).
However, its mRNA expression in the liver did not differ between GF and CV mice (Fig
5B). We also examined Se levels in plasma in GF and CV mice (Fig 5C). Whereas the 0ppm Se group showed several fold lower Se levels, there were no statistically significant
differences within each dietary group between GF and CV mice.
Influence of Se status and gut colonization on other trace elements. The
intestinal microbiota may be sensitive to changes in trace element levels, and, in turn, gut
colonization may influence host trace element status, either through competition for certain
elements or by modifying the processes of food absorption or digestion. Using ICPMS, we
analyzed concentrations of several trace elements in CV and GF mice subjected to the 3 Se
diets in liver, kidney, spleen, brain, and testes (Fig 6). Se levels in liver, kidney, and spleen
were sensitive to dietary Se, whereas its concentration in brain and testes did not differ
with changes in the Se dietary levels. Also, we found no difference in the Se levels
between GF and CV mice. Analysis of other trace elements, including Mn, Fe, Zn, Mo,
Cu, and As, did not reveal statistically significant differences between Se diets. Cd levels
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in the liver were higher in GF mice regardless of the diet, suggesting a possible role of the
gastrointestinal microbiotain assisting in detoxification of this element.

2.5 Discussion
Intestinal microbiota is sensitive to dietary Se status. Our results indicate that
dietary Se can affect both the composition of the existing microbiota and establishment of
gastrointestinal microflora. Particularly, in both experiments, the strongest effect was
observed within genus Parabacteroides of the phylum Bacteriodetes, which demonstrated
the opposite correlation with dietary Se supplementation. This finding might be explained
by the use of Se by various microorganisms and Se toxicity to certain organisms. We also
observed differential effects of Se across multiple phylotypes belonging to the phylum
Bacteriodetes. It is possible that the niches vacated by the effect of Se on Parabacteroides
were filled by other phylotypes within related taxonomic groups. The fact that multiple
groups showed increases while fewer groups, in general, showed decreases is consistent
with the overall effect of Se on increasing diversity of the microbiota. The differential
sensitivity of various microorganisms to dietary Se is likely due to differences in their
ability to uptake, store, use, and remove Se from the cell. In particular, the gut microbiota
may sequester Se for expression of its own selenoproteins. About one quarter of all
bacteria expresses selenoproteins, and, therefore, they require Se for optimal growth. For
example, Escherichia coli has 3 selenoproteins. The number of selenoproteins in bacteria
varies from 0 to 57. This use of Se by microorganisms decreases the availability of this
trace element for the expression of host selenoproteins. As a result, microbiota increases
the requirement of the host for Se. However, because of unavailability of the genomes for
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the majority of microorganisms that respond to Se status, it is not currently possible to
directly link sensitivity to dietary Se and occurrence of specific Se utilization pathways.
Bacterial colonization decreases total Se status of the host. Se is an essential
trace element required for synthesis and functions of 24 selenoproteins in mice. GPx1 and
TR1 are among the best studied mammalian selenoproteins. TR1 is an essential
selenoprotein that controls the redox state of thioredoxin. Thus, the thioredoxin system
(which is the main redox regulatory system) is dependent on dietary Se. GPx1 is the most
abundant mammalian selenoprotein that catalyzes glutathione-dependent reduction of
hydroperoxides. It is expressed at particularly high levels in liver and kidney. MsrB1 is
another important oxidoreductase, which repairs oxidatively damaged proteins by reducing
methionine sulfoxide residues to methionines. Various selenoproteins are differentially
regulated by dietary Se in mice. Some selenoproteins, such as GPx1 and MsrB1, are
sensitive to Se status, whereas several other selenoproteins, including TR1, are less
susceptible to changes in dietary Se. Thus, mice and other mammals have a priority for Se
supply that is selenoprotein- and tissue-specific. Under conditions of Se deficiency, GF
mice were shown to possess higher GPx and TR activities in liver and intestine [129].
They also had higher expression of GPx1 and its mRNA in the liver and colon. In addition,
plasma, liver, and cecum of these mice contained higher Se concentration compared to CV
animals [129]. In our study, which compared GF mice with their CV controls, we also
found GF mice to have elevated selenoprotein status, including higher GPx1 and MsrB1
activities and expression in liver and kidney. On the other hand, Se levels were similar in
GF and CV mice subjected to the same Se diets. This observation might be explained by
the fact, that in a previous study [129], GF and CV mice were subjected to the diets for 5
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wk, whereas in our work, we conventionalized the GF mice with the intestinal flora
prepared from C57BL/6J mice. Perhaps, at different Se levels in the diet, somewhat
different populations of microorganisms colonize the gut. In contrast to GPx1 and MsrB1
status in GF and CV mice, we observed a trend toward an increased level of SelP in CV
mice. A previous study investigated gene expression in colonic epithelial cells, derived
from germfree and bacteria-reconstituted mice [132]. SelP gene expression was found to
be down-regulated under these conditions. Moreover, SelP was only detected in the GF
mice. Since SelP is a transport form of Se, its expression contributes to the Se status of the
whole organism. This protein is regulated by the glucocorticoid receptor [133] and by
cytokines during inflammation. Its expression is decreased during certain pathologies
linked to chronic inflammation, such as liver cirrhosis and Crohn’s disease [38]. In
addition, it is induced by IL-10, an anti-inflammatory cytokine [133], but suppressed by
IFN-γ, TNF-α, IL-1, and TGF-β [134-136], which promote inflammation. The majority of
plasma SelP comes from the liver. Its increase in CV mice might be explained by the
indirect effect of cytokines on the expression of liver SelP or its increased use in organs of
GF mice that are dependent on this protein for supplies of Se.
Microbiota and the host Se status. Disruption of integrity of the intestinal
microbiota may lead to diseases, such as inflammatory bowel disease and cancer. Se
supplementation may be beneficial in the prevention of colon cancer and certain other
cancer types. Our data suggest that the sensitivity of the microbiota to dietary Se may be
relevant to the regulation of the host Se status. Our diets were chosen to mimic the dietary
Se intake in the human population. For example, the 0.1-ppm Se diet approximately
corresponds to the human recommended dietary allowance for adults, whereas 0.4 ppm Se
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[94] may correspond to the diet supplemented with 200 µg Se/d, which is the dose most
often used in human clinical trials involving Se. Thus, the effects observed with these diets
in mice may be relevant to the effects of the human microbiota in setting the status of trace
elements. In our experiments, the CV mice had higher requirements for Se compared to the
GF mice, likely due to sequestration of Se by gut microorganisms, which compete for Se
with the host. These data may also be relevant for understanding the mechanisms of Se
mediated protection against malignant transformation of the colon epithelium, but further
studies are required to test this idea.
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Figure 2. Mouse models for examining the interrelationships between dietary
Se, gut microbiota, and host Se status. A) Schematic illustration of selenoprotein
expression in mice subjected to Se-deficient (0 ppm Se), Se-sufficient (0.1 ppm Se), and
Se-enriched (0.4 ppm Se) diets. B, C) SelP expression was analyzed by Western blotting
(WB) in plasma of conventional (B) and GF and CV (C) mice fed the indicated Se diets for
8 wk (B) or 6 wk (C; top panels); gels stained with Coomassie blue served as loading
controls (bottom panels); 2 mice/group were analyzed.
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Figure 3. Effect of dietary Se on gut microbiota. A) Rarefaction analysis was
performed on pyrosequencing data from conventional and GF conventionalized animals.
Sequences were pooled from animals of a similar feeding level and aligned using the
complete linkage clustering at 97% cutoff available on the RDP pipeline, and clusters were
subjected to rarefaction analysis. B) Box and whisker plots depict relative abundance of
selected phylotypes showing statistically significant effects of dietary selenium (P < 0.05).
The taxonomic relationship of each phylotype is indicated above the relevant graph. Left
panels: phylotypes from conventional animals (orange boxes). Right panels: phylotypes
from GF conventionalized animals (light blue boxes). Vertical bars indicate range of
proportions for each treatment group; boxes indicate upper and lower bounds of the 95%
confidence intervals.
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Figure 4. Selenoprotein expression in GF and CV mice. Expression (A) and
specific GPx1 and MsrB1 activities (B) in livers and kidneys are shown; 3 mice/group
were analyzed. A) Expression of GPx1 and MsrB1 was analyzed by Western blots in livers
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(top panels) and kidneys (bottom panels) of CV and GF mice fed 0-, 0.1-, and 0.4-ppm Se
diets. B) GPx and MsrB activities in liver and kidney lysates of GF and CV mice fed 0-,
0.1-, and 0.4-ppm Se diets. Solid bars, CV mice; open bars, GF mice. *P > 0.05; Student’s
t test.
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Figure 5. Regulation of SelP expression by dietary Se in CV and GF mice. A)
SelP levels in plasma of CV and GF mice fed 0-, 0.1-, and 0.4-ppm Se diets, as analyzed
by Western blots. B) Liver SelP mRNA expression analyzed by quantitative PCR. SelP
mRNA expression in CV mice fed the 0-ppm Se diet was set to 1, and mRNA levels in
other groups were calculated relative to this basal level. Significance was analyzed with
Student’s t test. C) Se levels in plasma in CV and GF mice fed 0-, 0.1-, and 0.4-ppm Se
diets analyzed by ICP-MS. Values are expressed as means +/- sd.
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Figure 6. Trace elements in CV and GF mice maintained on Se diets. Trace
elements were analyzed with ICP-MS in tissues from CV and GF mice fed 0-, 0.1-, and
0.4-ppm Se diets, as described in Materials and Methods. Values are means +/- sd. Organs
in which trace elements were analyzed are indicated at the bottom of each panel.
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CHAPTER 3

15 kDa selenoprotein (Sep15) knockout mice: roles of Sep15 in redox
homeostasis and cataract development
Note: The results described in this chapter have been submitted for publication in
the Journal of Biological Chemistry:
Kasaikina M. V., Fomenko D. E., , Labunskyy V. M., Lachke S. A., Qiu W, Moncaster .
A., Zhang J., Wojnarowicz M. W., Kumar S. N, Malinouski M. M, Schweizer U., Tsuji P.
A., Carlson B. A., Maas R. L., Lou M. F., Goldstein L. E., Hatfield D. L. and Gladyshev
V. N. (2011) “15 kDa selenoprotein (Sep15) knockout mice: roles of Sep15 in redox
homeostasis and cataract development”
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3.1 Abstract
Sep15 is a thioredoxin-like, ER-resident protein involved in the quality control of
glycoprotein folding through its interaction with UGT. Expression of Sep15 is regulated by
dietary selenium and the unfolded protein response, but its specific function is not known.
In the current study, we developed and characterized Sep15 KO mice by targeted removal
of exon 2 of the Sep15 gene coding for the cysteine-rich UGT-binding domain. These KO
mice synthesized a mutant mRNA, but the shortened protein product could be detected
neither in tissues nor in Sep15 KO embryonic fibroblasts. Sep15 KO mice were viable and
fertile, showed normal brain morphology and did not activate ER stress pathways.
However, parameters of oxidative stress were elevated in the livers of these mice. We
found that Sep15 mRNA was enriched during lens development. Further phenotypic
characterization of Sep15 KO mice revealed a prominent nuclear cataract that developed at
an early age. These cataracts did not appear to be associated with severe oxidative stress or
glucose dysregulation. We suggest that the cataracts resulted from improper folding status
of lens proteins caused by Sep15 deficiency.

3.2 Introduction
Sep15 was identified in mammals 13 years ago as a protein of unknown function
[137]. The NMR structure of the Drosophila melanogaster Sep15 revealed a thioredoxinlike fold within its oxidoreductase domain, with Sec located in the predicted catalytic
position [20]. Previous studies showed that Sep15 resides in the endoplasmic reticulum
(ER) and interacts with UDP-glucose:glycoprotein glucosyltransferase (UGT) [138]. The
latter protein is a part of the calnexin-calreticulin glycoprotein folding cycle and is known
to be responsible for targeting unfolded glycoproteins for calcium-dependent transient
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glucosylation. Sep15 contains the ER targeting peptide, but lacks an ER retention signal;
the tight binding to UGT allows retention of Sep15 in the ER. These findings suggested
that Sep15 may assist UGT function and control folding or secretion of certain
glycoproteins.
Recently, Sep15 was found to be regulated by ER stress. Compounds causing mild
ER stress, such as tunicamycin and brefeldin A, up-regulated Sep15 expression. At the
same time, more robust ER stress agents, such as dithiothreitol (DTT), induced rapid
proteasomal degradation of Sep15 [22]. Presumably, disruption of Sep15-UGT interaction
due to reduction of disulfide bonds in the Sep15 UGT-binding domain displaced Sep15
from the ER. Expression of Sep15 is higher in tissues with secretory functions, such as
liver, kidney, prostate and thyroid [139]. Comparison of expression of Sep15 and other
components of the protein folding quality control machinery revealed similar expression
patterns in mouse brain, including enriched levels in hippocampus and cerebellum. This
observation further pointed to the role of Sep15 in glycoprotein folding [22].
Several studies suggested a role of Sep15 in cancer prevention. First, the human
Sep15 gene is located on chromosome 1p31, in the locus often deleted or mutated in
human cancers. In addition, Sep15 has two polymorphic sites which differentially regulate
expression of this protein in response to selenium supplementation [140]. Moreover, levels
of Sep15 were decreased in prostate cancer cell lines and in hepatocarcinoma compared to
non-transformed cells and tissues. Sep15 expression is also lowered in malignant lung,
breast, prostate and liver [141]. These observations suggest a role of Sep15 in tumor
suppression, possibly through regulation of folding and/or secretion of cancer-related
glycoprotein substrates; however, the specific function of Sep15 in this process is not
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understood. At the same time, recent research demonstrated an opposite role for Sep15 in
the promotion of growth of colon cancer cells [142, 143]. Stable knockdown of Sep15
significantly reduced growth of CT26 cells in culture and prevented formation of colonies
on the soft agar. Mice, injected with the Sep15-deficient cells developed fewer tumors and
did not form pulmonary metastases as did mice injected with control cells. However,
Sep15 deficiency had no effect on the growth of lung cells.
In the present study, we describe Sep15 KO mice, lacking exon 2 of the gene.
Although the mutant mRNA was detected, the shortened dysfunctional Sep15 form was
not present in these mice. Analyses of Sep15 KO mice did not reveal any signs of ER
stress and any gross abnormalities. However, livers of Sep15 KO mice showed increased
levels of malondialdehyde and protein carbonyls, indicative of mild oxidative stress.
During the course of further analyses, we found that Sep15 mRNA was enriched in the
developing ocular lens. Consistent with this observation, deficiency in the protein due to
Sep15 KO resulted in the development of cataract. This study highlights the roles of Sep15
in redox homeostasis and glycoprotein folding and indicates its function in the
maintenance of lens transparency.

3.3 Experimental Procedures
Development of Sep15 KO mice. The Sep15 KO construct was prepared as
follows. A 4,202 bp fragment of Intron 1 was amplified from 129/Sv mouse genomic DNA
by

nested

PCR

with

the

following

primers:

CCAGTTAACTTCTACGGGTCTGTTACAAGTGGT-3’
GTCCAGGCTGGCCCTGAACTAGCTCTGTGC-3’;

Round

1

and
and

Round

5’5’-

2

5’-

GTGGTCTCGAGTGGAAGCATCATTGACAGTTGATGGTACTGAAGTG-3’ and 5’-
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CTGTGCTCGAGACGACCTCACCCTGATTCTCCTGTCCAGTTCAGG-3’.

The

amplified fragment was cloned into the XhoI site of the pPNT vector. A second fragment
of 4,246 bp of Intron 2 was amplified from 129/Sv mouse genomic DNA by nested PCR
with

the

following

primers:

Round

1

GCATACCAGGATTCATTCCACTGAGGCTGTCC-3’
ACCCATCTTTATGGACGGTGTCACATGTC-3’;

5’-

and
and

5’-

Round

AGGACCGGATCCCAGGATCACCATTGCCCTAGGCTTCCTGG-3’

2

5’-

and

5’-

CCTGTGGATCCTGACTCTGCTGGCTGTGGTGGTTGTAGAGAAGC-3’.

The

amplified fragment was cloned into the BamHI site of pPNT vector. Correct insert
orientation of fragments was confirmed by restriction analysis. The construct was digested
with NotI, DNA fragments were separated by agarose gel electrophoresis and the targeting
DNA was purified from the gel. 129/Sv embryonic stem cells were transfected with the
targeting construct and recombinants were selected by growing stem cells in a neomycincontaining medium. Clones with successful construct recombination were identified by
nested PCR with the following primer pairs for the neo-cassette and genomic DNA that
was

not

part

of

the

targeting

construct:

Fragment

1,

GGGAAGACAGTACCTTGTCATGTAAGTGG-3’

Round

1

and

5’5’-

GCTGCTAAAGCGCATGCTCCAGACTGCCTTGG-3’; Fragment 1, Round 2 5’CCAGTTAACTTCTACGGGTCTGTTACAAGTGG-3’,
CCTACCCGGTAGAATTGACCTGCAGG-3’;

Fragment

GAACGAGATCAGCAGCCTCTGTTCCAC-3’
ACCCATCTTTATGGACGGTGTCACATGTC-3’.
GTTCTAATTCCATCAGAAGCTGACTCTAGA-3’

5’2,

Round

1

and
Fragment

2,
and

5’5’-

Round

2

5’5’-
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CAGTCATGTTGCGCTGCCTTCCTGCCT-3’. Cells with proper construct integration
were microinjected into C57Bl/6 blastocysts. The resulting chimeric mice were then mated
with C57Bl/6 mice. Germline transmission was confirmed by nested PCR as described
above. The KO allele was transferred to the C57Bl/6 background through five rounds of
crossbreeding with C57Bl/6 mice, and homozygous Sep15 KO animals were then
generated by crossbreeding of Sep15 KO heterozygous mice. The KO phenotype was
confirmed by southern blotting,

75

Se metabolic labeling and immunoblot analyses as

described in the Results section. For the RT-PCR experiments, total liver RNA was
isolated by TRIzol extraction according to the manufacturer’s protocol (Invitrogen).
Genomic DNA was removed using a DNA removal kit (Ambion). RNA was quantified
with a spectrophotometer, and 5 µg were transcribed with 50 ng of random primer and 200
U of SuperScript III reverse Transcriptase (Invitrogen). 1 µL of the resulting cDNA was
used for analysis with primers specific for various regions of the mouse Sep15 gene.
Isolation of mouse embryonic fibroblasts (MEFs) and metabolic labeling with
75

Se. Embryos generated from wild type (WT) and Sep15 KO mice were dissected out at

the 13.5 embryonic day and separated from maternal tissues. The embryos were treated
with 0.05% trypsin at 4 °C for 30 min and incubated at 37 °C for 1 h. Embryonic cells
were cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 20%
fetal bovine serum, 2 mM glutamine, 50 µM β-mercaptoethanol and 100 units/ml
penicillin/streptomycin. After 4 weeks, an aliquot of cells was frozen, and another aliquot
was used for further experiments. For the analysis of Sep15 expression, WT and Sep15 KO
MEFs were grown in DMEM supplemented with freshly neutralized

75

Se selenious acid

(specific activity 1000 Ci/mmol, final concentration in the medium 1 nM) for 24 h. Sep15
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was immunoprecipitated using a Protein G immunoprecipitation kit (Sigma) and 5 µl of
Sep15-specific antibodies. Selenoproteins were visualized by SDS-PAGE followed by
autoradiography using a PhosphorImager.
Cloning and in vitro expression of Sep15 and Sep15∆2 forms. To analyze for the
possibility of expression of the Sep15 form lacking the Cys-rich UGT-binding domain
encoded by exon 2 (Sep15∆2), Sep15∆2 nucleotide sequence was amplified from Sep15 KO
cDNA

(prepared

from

total

liver

RNA)

ATCACTCGAGATGGCGGCAGGGCAGG-3’

with

primers

and

5’5’-

TGACTCTAGATTAATGATGATGATGATGATGTATGCGTTCCAACTTCTCG-3’
containing XhoI and XbaI restriction sites, and subcloned into pCI-neo using the
corresponding restriction enzymes. The SECIS element was separately amplified with 5’TGACTCTAGATTAGTAGTTTTTATACTAATC-3’

and

5’-

ATGACGATCTGCGGCCGCTTTTTTTTAAAATCAAACATATTTGAAAG-3’ primers
and cloned into the resulting vector at Xba1 and Not1 sites. For localization experiments,
full-length Sep15 and Sep15∆2 sequences were cloned into pEGFPN1 vector with primers
5’-ATCAGCTAGCATGGCGGCAGGGCAGG-3’

and

5’-

ACTTACAATATTACCGGTATTATGCGTTCCAACTTCTCG-3’ containing NheI and
AgeI restriction sites. All constructs were verified by sequencing. Sec was substituted with
Cys

by

site

directed

mutagenesis

CTTGAAGTCTGCGGATGTAAATTGGGGAGGTTCC-3’

with

primers
and

5’5’-

GGAACCTCCCCAATTTACATCCGCAGACTTCAAG-3’ (the introduced mutations are
underlined).
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Cell culture studies. Human HEK 293, mouse NIH 3T3 cells, and MEFs were
cultured in DMEM medium supplemented with 10% FBS, 100 units/mL penicillin, and
100 units/mL streptomycin. Transfections were carried out using Lipofectamine
(Invitrogen) according to the manufacturer’s instructions. To analyze expression of Sep15
and Sep15∆2, HEK 293 cells were transfected with pCI-neo vector coding for full-length
Sep15 and Sep15∆2 forms, and, 18 h after transfection, medium was replaced with that
containing freshly neutralized

75

Se selenious acid (specific activity 1000 Ci/mmol, final

concentration in the medium 1 nM). Cells were metabolically labeled for 24 h, and
expression of selenoproteins was analyzed by SDS-PAGE followed by autoradiography.
To further analyze expression of full-length and Sep15∆2 forms, NIH 3T3 cells
were grown in 6-well plates and transfected with the corresponding EGFP fusion
constructs or with an empty vector. Twenty-four hours after transfection, the original
medium was replaced with serum-free medium, and after an additional 24 h, cells and
media were collected. Cell lysates were prepared using CellLytic buffer (Sigma) according
to the manufacturer’s instructions. The conditioned media were concentrated to 40 µl using
Centricon concentrators (Millipore). Cell extracts and concentrated media samples were
analyzed by Western blotting using GFP-specific antibodies (Sigma).
To further characterize expression of full-length and Sep15∆2 forms, NIH 3T3 cells
were grown on cover slips, transfected with the corresponding constructs in pEGFPN1
expression vector, and 24 h after transfection, treated with 1 µM ER-Tracker Blue-White
DPX dye (Invitrogen) for 20 min. Then, cells were washed with PBS, fixed in 4%
formaldehyde in PBS and mounted with mount media. Images were collected using a
BioRad MRC1024ES laser scanning microscope.
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Metabolic labeling of WT and Sep15 KO mice. WT, heterozygous and
homozygous Sep15 KO mice were injected each with 40 µCi of freshly neutralized

75

Se

selenious acid and maintained on a 12 h light/dark cycle and a regular diet. After 48 h,
mice were sacrificed and extracts prepared from various tissues in ice-cold PBS, pH 7.6,
supplemented with complete protease inhibitor mixture (Roche Applied Science). Extracts
from the indicated tissues were subjected to SDS-PAGE, and proteins were transferred
onto polyvinylidene difluoride membranes and analyzed with a PhosphorImager.
Tissue and blood preparation. Blood was obtained from sacrificed Sep15 KO and
control mice from the heart vein. Brain and prostate tissues were immediately fixed in 10%
neutral buffered formalin and washed with PBS. PBS-washed tissues were embedded in
paraffin and cut on a standard microtome to 5 µm sections. The sections were
deparaffinized in xylene and stained with hematoxylin (Invitrogen) and eosin (Sigma) to
reveal the fine tissue structure. Images were taken using a light Olympus AX70
microscope. For prostate-specific antigen (PSA) analysis, erythrocytes were removed by
centrifugation, and 30 µg of serum proteins were analyzed by Western blotting with PSAspecific antibodies (Dako). Brains were stained with the indicated antibodies at dilutions of
1:1,000–1:5,000 at 4 °C overnight.
Analyses of oxidative stress parameters. Protein extracts from liver, kidney, heart,
testis, and brain were prepared in PBS containing a complete protease inhibitor mixture.
Malondialdehyde was measured using the Oxiselect TBARS assay kit (Cell Biolabs)
according to the manufacturer's instructions. Protein carbonyl content was assayed using
2,4-dinitrophenyl hydrazine and (molar extinction coefficient of 22 mm-1 cm-1). Total and
protein thiol contents were measured using 5,5′-dithiobis (2-nitrobenzoic acid).
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Analysis of SelP secretion in hepatocytes. Hepatocytes of WT and Sep15 KO
mice were obtained according to the previously published procedures [144, 145]. Briefly,
livers from 3-month old mice were perfused with Ca2+ and SO42- free buffer (6 mM
glucose, 115 mM NaCl, 25 mM NaHCO3, 6 mM KCl, 1 mM MgCl2x6H2O, 1mM
NaH2PO4). After liver was cleared from the blood, collagenase (700 units/ml, Sigma) was
added at the concentration of 0.1 mg/ml. Tissues were removed and dissociated by gentle
rubbing in perfusion buffer. The suspension was then filtered through a 70 µm cell strainer
by gravity flow. Then, hepatocytes were washed 3 times in Williams E medium (Sigma)
supplemented with 2 mM L-glutamine (Invitrogen) seeded on collagen-coated 5 cm plates.
Fourty eight hours later, the medium was replaced with 3 ml of serum-free medium
containing freshly neutralized

75

Se selenious acid and supplemented with DMSO or ER

stress-inducing agents 1 mM DTT, 10 µg/ml brefeldin A, 5 µg/ml tunicamycin, or 20 µM
monensin. Cells and media were collected 24 h later, and media samples were concentrated
as described above for NIH 3T3 cells. Cell lysates and concentrated media were analyzed
by SDS-PAGE followed by autoradiography.
Tunicamycin injection. WT and Sep15 KO mice were given a single 1 µg/g body
weight intraperitoneal injection of a 0.05 mg/ml suspension of tunicamycin in 150 mM
dextrose as described [146]. These mice were euthanized 72 h after injection, and their
livers were removed. Protein lysates were resolved by SDS-PAGE and analyzed by
Western blotting using antibodies specific for Sep15, BiP and β-actin.
Phenotypic screening of cataracts. Phenotypic screening was performed via slit
lamp examination as described [147]. Mouse pupils were dilated by 1% atropine, and 15
min later lenses were examined with a slit lamp. Observed opacities were quantified using
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Lens Opacities Classification System, version II (LOCS II) [147-149]. For ex vivo
phenotyping, eyes were dissected for lens phenotyping by ex vivo dark field
photomicroscopy as previously described [150, 151]. For measurement of glucose levels,
mice were fasted for 8 h. Glucose was measured in blood from the tail vein using Elite
system (Bayer) glucometer as described by the manufacturer. The data were analyzed with
ANOVA (p<0.05 for limit).

3.4 Results
Generation of the Sep15 KO mice. Sep15 KO mice were generated by
homologous recombination. The KO construct was designed to exchange exon 2 with the
selection marker followed by a transcription termination signal (Fig 7A, B). Genotypes of
mice were confirmed by PCR analysis. However, subsequent RT-PCR analysis showed a
signal of Sep15 mRNA in Sep15 KO tissues. To determine the organization of this mRNA,
we used primer pairs for various parts of the Sep15 mRNA (Fig 7C). Amplification with
primers specific for the first and third exons gave fragments of different sizes in WT and
Sep15 KO mice, while the use of primers downstream of exon 3 showed fragments of
similar size. Further sequencing of the fragment amplified with primers specific for exons
1 and 5 revealed that the truncated Sep15 KO mRNA lacked exon 2. However, since the
reading frame was preserved and the shortened mRNA form had both an in-frame UGA
codon and SECIS element in the 3’-UTR, the possibility that the mutant mRNA supported
Sec insertion and therefore selenoprotein synthesis had to be considered. To test for
possible expression of the shortened protein product in Sep15 KO mice, we prepared
MEFs from WT and Sep15 KO mice and subjected them to metabolic labeling with

75

Se

(Fig 7D). Selenoprotein patterns were similar in WT and Sep15 KO MEFs, with the
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exception of a 14 kDa band that was missing in Sep15 KO MEFs. This band corresponded
to the migration property of Sep15 following removal of the N-terminal signal peptide. To
verify that the 14 kDa band was Sep15, we carried out immunoprecipitation with Sep15specific antibodies. This analysis precipitated a 14 kDa protein in WT MEFs, but not in
Sep15 KO MEFs (Fig 7D). In addition, we did not detect any selenoprotein bands
migrating lower than 14 kDa in either WT or Sep15 KO samples subjected to
immunoprecipitation. These data suggested that Sep15 KO mice express neither Sep15 nor
its shortened form lacking sequences encoded by exon 2.
Characterization of the truncated Sep15∆2 form. Since Sep15 KO mice
synthesized a shortened mRNA form, we further examined the possibility that it could
code for a protein fragment. The predicted size of Sep15 selenoprotein lacking the region
encoded by exon 2 (further designated Sep15∆2) is 107 amino acids (11.6 kDa) (Fig 8A,
B). Transfection of the Sep15∆2 construct into HEK 293 cells did not reveal a band of the
expected size when cells were labeled with

75

Se. We also tested the possibility that

Sep15∆2 was secreted by cells because it lacked the domain that retained the protein in the
ER due to interaction with UGT. To exclude this possibility, we prepared constructs for
Cys mutants (i.e., Cys replacing Sec) of Sep15∆2 and Sep15 fused with GFP. HEK 293
cells transfected with these constructs showed Sep15∆2-GFP and Sep15-GFP bands, and
these protein forms were absent in the medium (Fig 8D). We also transfected NIH 3T3
cells with the same constructs and examined localization of Sep15 protein forms (Fig 8E).
Full-length Sep15-GFP colocalized with the ER tracker, while Sep15∆2-GFP showed a
different localization pattern, wherein the protein seemed to be in granules (it did not
correspond to mitochondria or lysosomes). Thus, Sep15∆2 was not expressed in transfected
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mammalian cells, based on Western blot data, extremely sensitive
lysates, and immunoprecipitation of Sep15 from

75

75

Se labeling of cell

Se-labeled cells. When Sep15∆2 was

fused to a large globular protein (i.e., GFP) and, in addition, had its Sec replaced with Cys
(Sec insertion is very slow and replacing this residue with Cys is a method to dramatically
increase protein expression), the protein could be expressed, but it changed localization.
We conclude from the above observations that Sep15 KO cells lack functional Sep15.
Absence of Sep15 does not affect expression of other selenoproteins.
Selenoprotein expression depends on availability of dietary Se [128]. In addition, removal
of one selenoprotein may affect expression of other selenoproteins, e.g., due to increased
availability of Sec-tRNA or by influencing redox homeostasis. To examine this possibility,
WT and heterozygous and homozygous Sep15 KO mice were metabolically labeled with
75

Se (Fig 9). However, expression of other selenoproteins was unchanged.
Oxidative stress in Sep15 KO mice. We examined parameters of oxidative stress

in livers of WT and Sep15 KO mice. Sep15 KO livers showed increased levels of
malondialdehyde (p <0.0001) and protein carbonyls (p <0.0001), while amounts of total
thiols and protein thiols were found to be decreased compared to controls (p<0.05) (Fig
10). The data show increased lipid and protein oxidation, and suggest mild oxidative stress
in Sep15 KO livers.
Analysis of Sep15 KO mice for prostate and brain pathologies. Sep15 is
expressed at elevated levels in prostate, liver, kidney, testis, and brain. At the same time,
Sep15 expression is decreased in malignant prostate cell lines and in hepatocarcinoma
[22]. We examined Sep15 KO mice for phenotypes associated with prostate and brain.
Prostate was examined in 1.5 year-old males (n=13) (Fig 11A. No signs of neoplasia were
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observed. PSA is a plasma protein, whose expression is increased during prostate
pathologies, such as inflammation and malignant transformation. No differences in PSA
levels were observed in serum samples of WT and Sep15 KO mice (Fig 11B).
Selenoprotein deficiency is also known to be associated with neuronal pathology
[40]. For example, mice lacking SelP show seizures and ataxia and die before weaning
when fed a Se-deficient diet [152]. Comparative analysis of gene expression data in the
Allen Brain Atlas revealed expression of all selenoproteins and selenocysteine
incorporative machinery in the brain, including high expression of Sep15 [153]. In
addition, disruption of neuronal expression of selenoproteins led to neurological symptoms
and neurodegeneration [114, 154]. Similar symptoms were observed in glutathione
peroxidase 4 (GPx4) KO mice [155] and in TrsptAE/AE mice expressing hypomorphic
tRNA(Ser)Sec [114]. Sep15 expression is high in Ammon’s horn and dentate gyrus of
hippocampus and in Purkinje cells of the cerebellar cortex [153]. We analyzed brains of
Sep15 KO mice (Fig 11). The hippocampal area of Sep15 KO mice showed no signs of
astrogliosis, and its levels of glial fibrillary acidic protein and parvalbumin were similar to
those in WT mice. Thus, Sep15 deficiency did not lead to the loss of parvalbumin positive
interneurons observed in mouse models with general deficiency in selenoprotein
expression. Analysis of cerebellum morphology of Sep15 KO mice also did not reveal
abnormalities. Thus, Sep15 deficiency does not lead to spontaneous neurodegeneration,
consistent with an apparent lack of behavioral phenotypes.
Sep15 deficiency does not influence SelP secretion. As a UGT-binding partner,
Sep15 may be involved in protein folding and secretion. Sep15 is also regulated by the
unfolded protein response (UPR). SelP is a major plasma selenoprotein, synthesized in the
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liver and transporting Se to other organs. SelP maturation, intracellular transport and
secretion occur through the common ER-Golgi pathway in the liver [156]. We examined
the possibility that Sep15 KO affects SelP secretion. Hepatocytes from WT and Sep15 KO
mice were isolated and metabolically labeled with

75

Se. The cells were also treated with

compounds that compromize function of the ER-Golgi pathway (Fig 12). This treatment
did not affect the viability of cells (data not shown). Treatment of hepatocytes with
brefeldin A is known to abrogate SelP secretion, which is what we observed in both WT
and Sep15 KO hepatocytes, while treatment with tunicamycin and monensin caused
accumulation of intracellular non-glycosylated or partially glycosylated SelP forms.
However, this difference disappeared after the treatment with tunicamycin, an inhibitor of
GlcNAc phosphotransferase. As expected, treatment with this compound induced
expression of BiP in Sep15 KO hepatocytes.
Sep15 deficiency does not lead to activation of the UPR. To further assess the
function of Sep15, WT and Sep15 KO mice were injected intraperitoneally with 1 µg/g
body weight tunicamycin or vehicle and sacrificed 72 h after injection. This treatment
induced both BiP and Sep15 expression in WT mice (Fig 13), consistent with previous data
in cell culture [22]. BiP was elevated similarly in WT and Sep15 KO mice, so the absence
of Sep15 did not augment the UPR.
Sep15 mRNA expression is progressively lens-enriched during mouse
development. Because our data suggested that Sep15 may play a role in the quality control
of protein folding, we hypothesized that deficiency in this protein may lead to protein
misfolding or aggregation. A prominent human disease associated with altered protein
folding is cataract, with opacities caused by aggregation of lens structural proteins, such as
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α-crystallins. It has been proposed that genes that are expressed in a lens-enriched manner
in the developing mouse lens may have a functional role in the development and
maintenance of lens transparency and therefore may represent candidate genes for cataract
[157, 158]. In this approach, lens enrichment of a candidate gene is scored against its
expression in whole embryonic tissues at various stages in development (Lachke and
Maas, unpublished). This approach has been successful in identifying previously described
cataract loci. Therefore, we investigated if Sep15 mRNA was enriched in the lens during
stages of lens invagination (E10.5) through primary fiber cell differentiation (E12.5). We
found expression of Sep15 mRNA to get progressively enriched at E12.5 (Fig 14).
Development of cataract in Sep15 KO mice. To directly assess cataract formation
in Sep15 KO mice, we carried out slit lamp examination for cataract scoring, which
revealed lens opacity in both male (n=10) and female (n= 7) Sep15 KO mice (Fig 15A).
Observed opacities were quantified using Lens Opacities Classification System, version II.
Nuclear changes were classified by scoring the degree of opalescence. In our experiment,
clear lens was assigned a grade of 0 and the fully opaque lens a grade of 5. The opacity
grade increased with age, based on the comparison of 1.5 and 6-month old females (n=12).
Fundus camera examination was also conducted, and representative images are shown in
Fig 15B. A group of Sep15 KO mice was examined by slit lamp followed with ex vivo
phenotyping, including lens dissection followed by microscopy analyses. In this
experiment, we used 2.5-month old males (n=3) and females (n=3) as well as 10 month old
males (n=4) and females (n=3). Both lenses of each KO mouse showed nuclear opacity,
which increased in size with age. Sep15 KO mice predominantly developed nuclear
cataract. Representative images of the lenses dissected from 2 month and 10 month Sep15
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KO and control mice are shown in Fig 15 C-H and. Although some of the 10 month old
control mice developed age-related punctate opacity (Fig 15H), the cataract in Sep15 KO
mice was more prominent and occurred in all mice. Moreover, all examined 2 month old
Sep15 KO mice had cataract, whereas it was not observed in 2 month old controls. These
data show that Sep15 KO mice develop nuclear cataract.
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3.5 Discussion
Sep15 is an ER-resident protein implicated in the calnexin-dependent quality
control cycle. Our previous studies showed that Sep15 forms a 1:1 complex with UGT, a
protein that recognizes improperly folded or partially unfolded glycoproteins and subjects
them to the calnexin cycle. In addition to the Cys-rich UGT-binding domain, Sep15 has a
thioredoxin-like domain containing a redox active CxU (Cys and Sec separated by another
residue) motif, suggesting a thiol oxidoreductase function for this protein. Sep15 is also
differentially regulated by ER stress. Mild stress, e.g., caused by tunicamycin or brefeldin
A treatments, induces Sep15 expression, whereas acute stress, e.g., caused by treatments
with disulfide-reducing DTT or thapsigargin, a compound that disrupts calcium flux from
the ER, leads to a rapid proteasomal degradation of Sep15 [22]. However, the specific
function of Sep15 in these processes is not known. Sep15 is expressed at elevated levels in
secretory organs, such as prostate, liver, kidney, testes, and brain. At the same time, Sep15
expression was shown to be decreased in prostate cancer cells and in hepatocarcinoma. It
was also found that stable Sep15 knockdown makes cells more susceptible to oxidative
stress.
In the current study, we generated and characterized Sep15 KO mice, which were
viable and fertile, and with no obvious phenotypes during development and growth. These
mice were obtained by deleting exon 2 coding for the UGT-binding domain of Sep15.
Although the mRNA for a shortened Sep15 form was synthesized, the corresponding
protein could not be detected under any conditions tested. Moreover, even when this
protein form was forced into expression in cell culture by fusion with GFP and
replacement of Sec with Cys, it had an abnormal localization. Therefore, Sep15 KO mice
lacked functional Sep15.
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Initial characterization of Sep15 KO mice revealed no phenotypes with regard to
expression of other selenoproteins, susceptibility to treatments that induce ER stress, or
protein secretion. Strong interaction between Sep15 with UGT implied the role of Sep15 in
the quality control of glycoprotein folding. Thus, we analyzed the effect of Sep15
deficiency on secretion of plasma glycoprotein SelP. However, no differences were found
between WT and Sep15 KO hepatocytes subjected or not subjected to ER stress.
Apparently, SelP is not a target of Sep15. Previous experiments in cell culture also
suggested the involvement of Sep15 in the UPR. Therefore, we examined the levels of BiP
(a marker of UPR) in WT and Sep15 KO hepatocytes. Tunicamycin treatment led to a
robust increase in BiP expression in Sep15 KO hepatocytes; however, this protein was
induced to a similar level in WT and Sep15 KO mice.
Although the observed phenotypes of Sep15 KO mice were mild, we reasoned that
since Sep15 is elevated by the UPR, Sep15 deficiency might modulate development of
certain ER stress associated diseases. One such disease is cataract formation resulting from
improper protein folding and posttranslational modifications, leading to decreased lens
transparency. It has been proposed that lens-enriched genes may represent promising
targets associated with cataract formation. Recently, deficiency of a gene with a highly
lens-enriched expression pattern was found to cause congenital cataracts in humans, mice
and chicken [157, 158]. We found that Sep15 mRNA was progressively enriched in three
critical stages of mouse lens development. In addition, transcripts for several proteins
functionally linked to Sep15 were found to be enriched in the lens (e.g., UGT1,
calreticulin) while others (e.g., UGT2, calnexin, ERp57, SelM) although not enriched are
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expressed in the lens. This provides further support that the Sep15 function is important in
the lens.
Further analysis revealed that nearly every Sep15 KO mouse developed mild
nuclear cataract, some as early as 1.5 months of age. One of the factors that may influence
cataract formation is glucose imbalance. We analyzed glucose levels in fasted mice, but
they were comparable to those in WT controls (Fig 16). Cataracts may also result from
increased protein oxidation and aggregation. Indeed, we found that Sep15 KO mice
showed increased levels of both lipid and protein oxidation. To further examine this
possibility, we analyzed the ratio of reduced to oxidized glutathione and levels of thiols in
lenses. However, these parameters were similar in Sep15 KO and WT lenses (Fig 16 B, C).
Therefore, it remains to be determined if Sep15 KO induced cataracts are directly
associated with general oxidative stress. Another explanation for cataract formation is the
improper folding or disulfide status of Sep15 targets. For example, similar symptoms were
previously described in mice lacking connexin 46 [159, 160] Connexins are a family of
gap junction proteins, whose mutations are associated with cataract development in human
subjects [161, 162]. In the case of Sep15 KO cataracts, further studies are needed to
determine the precise function of Sep15 in protein folding, but interaction of this
selenoprotein with the protein folding sensor is consistent with the role of protein
misfolding in Sep15-dependent cataract development.
Overall, this study shows that the absence of Sep15 does not affect viability and
does not lead to obvious phenotypes in mice. To better understand Sep15 function and the
role of this selenoprotein in glycoprotein folding, it would be important to identify the
subset of Sep15 targets and examine their posttranslational modifications in WT and Sep15
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KO mice. Cataract is the major cause of blindness in the world. Several types of cataracts
are associated with excessive ER stress and the UPR [163, 164]; however, little is known
about the link between defective protein secretion pathways and cataract formation. Future
experiments in this direction may lead to a better understanding of the association between
abnormal glycoprotein folding/modification and human disease.
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Figure 7. Preparation of Sep15 KO mice. (A) Structure of the mouse Sep15 gene.
(B) Structure of the KO allele. Coding regions are shown in orange and DNA flanking
regions used for homologous recombination are shown in green. The second exon was
replaced with the Neo gene containing a transcription termination signal. (C) RT-PCR
analysis of Sep15 mRNA in WT and Sep15 KO mice with primers for the indicated
regions of Sep15. Aldolase gene was used as a control. (D) Analysis of Sep15 expression
in MEFs derived from WT and Sep15 KO mice. Cells were labeled with 75Se followed by
immunoprecipitation with antibodies specific for Sep15. Two lanes on the left show
labeled MEFs. Immunoprecipitated (i.p.) and flow through (flow) fractions are shown for
each MEF line in the right lanes. Arrow on the right indicates migration of Sep15.
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Figure 8. Characterization of a shortened Sep15 form. (A) Amino acid sequence
and predicted size of Sep15∆2. (B) Schematic representation of domain organization of
Sep15 and its correspondence to gene structure. (C) Sep15 and Sep15∆2 were expressed in
HEK 293 cells followed by labeling of cells with

75

Se. Expression of proteins was

compared to the selenoprotein expression profile in MEFs derived from WT and Sep15 KO
mice. (D) Western blot analysis of Cys mutants of Sep15-EGFP and Sep15∆2-EGFP
expressed in NIH 3T3 cells. Protein expression was analyzed in cell extracts and
concentrated media. (E) Localization of Sep15 and Sep15∆2. Colocalization of Sep15
forms (green) and the ER marker (blue) is shown.
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Figure 9. Metabolic labeling of WT and Sep15 KO mice with

75

Se. WT

(Sep15+/+), and heterozygous (Sep15+/-) and homozygous (Sep15-/-) Sep15 KO mice were
injected each with 40 µCi of

75

Se. Selenoprotein expression was analyzed in indicated

organs by SDS-PAGE followed by PhosphorImager.
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Figure 10. Oxidative stress in Sep15 KO mice. Levels of malondialdehyde,
protein carbonyls, total thiols and protein thiols in livers of WT (white bars) and Sep15 KO
(black bars) mice are shown as mean +/- SD. (* p<0.001).
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Figure 11. Analyis of prostate and brain pathologies in Sep15 KO mice. (A)
H&E staining of prostate sections in WT and Sep15 KO mice. (B) Western blot analysis of
PSA in serum of WT and Sep15 KO mice (upper panel). Coomassie Blue staining as a
protein loading control (loading). (C) Analysis of brain sections: Nissl, GFAP and
parvalbumin staining of the hippocampal area of WT and Sep15 KO mice. Also shown are
immunohistochemistry of cerebral cortex area with GFAP antibodies and Nissl staining of
cerebellum.
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Figure 12. Sep15 deficiency does not affect SelP secretion. Hepatocytes were
isolated from WT and Sep15 KO mice and metabolically labeled with 75Se.
PhosphorImager analysis of cellular extracts (left panel) and concentrated media (right
panel). Membranes
nes were further analyzed with BiP and β-actin
actin (lower left panels) and SelP
(lower right panel) antibodies.
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Figure 13. Sep15 deficiency does not lead to activation of the UPR. WT and
Sep15 KO mice were injected intraperitoneally with tunicamycin (Tun) (1 µg/g body
weight) or vehicle. 72 h after injection, mice were euthanized, livers extracted and protein
lysates from livers probed by immunoblot assays with polyclonal antibodies specific for
Sep15 and BiP, or monoclonal β-actin antibody as a loading control.
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Figure 14. Enrichment of Sep15 mRNA during lens development. Sep15
mRNA expression was analyzed at the indicated stages of embryogenesis and compared to
the whole body Sep15 mRNA expression (WB).
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Figure 15. Development of cataract in Sep15 KO mice. (A) Quantification of slit
lamp examination of control and Sep15 KO mice. Opacity was quantified using the Lens
Opacities Classification System, version II. The scale was from completely clear (grade 0)
to fully opaque (grade 5) lens. L indicates left and R right. (B) Representative images of
opacities in Sep15 KO mice using Fundus Camera. Six-month old WT and Sep15 KO
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females were used. L indicates left and R right. (C-H) Representative cataracts in Sep15
KO mice. Each panel shows lens from the same animal. Left images represent in vivo slit
lamp examination, and the right images show dark field analyses of the same lens
examined in vitro. (C, D) Representative lenses from 2-month-old Sep15 KO females.
Nuclear opacity is shown with a red arrow. (E) 2-month-old WT female (control), which
shows no nuclear opacity. (F, G) 10-month-old Sep15 KO females. Nuclear opacity is
shown with red arrows. (H) 10-month-old WT female, which developed age-related
punctate opacity.

81

Figure 16. Comparison of glucose levels and oxidative stress parameters in
lenses of WT and Sep15 KO mice. (A) WT and Sep15 KO mice were fasted overnight
and blood was analyzed for glucose levels (n=9 for WT and 12 for Sep15 KO mice). (B)
Lenses were extracted from WT and Sep15 KO mice. Protein extracts were analyzed for
(B) ratio of oxidized to reduced glutathione and (C) total thiol levels. In each group, n=3.
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CHAPTER 4

Reduced utilization of selenium by naked mole rats due to a specific defect in
GPx1 expression

Note: The results described in this chapter have been published.
Kasaikina, M.V., Lobanov, A.V., Malinouski, M.Y., Lee, B.C., Seravalli, J.,
Fomenko, D.E., Turanov, A.A., Finney, L., Vogt, S., Park, T.J., Miller, R.A., Hatfield,
D.L. & Gladyshev, V.N. 2011, "Reduced utilization of selenium by naked mole rats due to
a specific defect in GPx1 expression", Journal of Biological Chemistry, in press.
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4.1 Abstract
Naked mole rat (MR) Heterocephalus glaber is a rodent model of delayed aging
because of its unusually long lifespan (>28 years). It is also not known to develop cancer.
In the current work, tissue imaging by X-ray fluorescence microscopy and direct analyses
of trace elements revealed low levels of selenium in the MR liver and kidney, whereas MR
and mouse brains had similar selenium levels. This effect was not explained by uniform
selenium deficiency as methionine sulfoxide reductase activities were similar in mice and
MR. However, glutathione peroxidase activity was an order of magnitude lower in MR
liver and kidney than in mouse tissues. In addition, metabolic labeling of MR cells with
75

Se revealed a loss of the abundant GPx1 band, whereas other selenoproteins were

preserved. To characterize the MR selenoproteome, we sequenced its liver transcriptome.
Gene reconstruction revealed standard selenoprotein sequences except for GPx1, which
had an early stop codon, and SelP, which had low selenocysteine content. When expressed
in HEK 293 cells, MR GPx1 was present in low levels and its expression could be rescued
neither by removing the early stop codon nor by replacing its SECIS element. In addition,
GPx1 mRNA was present in lower levels in MR liver than in mouse liver. To determine if
GPx1 deficiency could account for the reduced selenium content, we analyzed GPx1
knockout mice and found reduced selenium levels in their livers and kidneys. Thus, MR is
characterized by the reduced utilization of selenium due to a specific defect in GPx1
expression.

4.2 Introduction
Naked mole rat (Heterocephalus glaber; MR) is a unique organism in the
mammalian order rodentia. It is an attractive model to study aging due to an extraordinary
lifespan (more than 28 years), which is unprecedented for rodents of similar body size.
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Aging in MRs is characterized by very slow age-related declines that do not significantly
affect breeding capacity, social behavior and daily activity [165-167]. MR evolved a
unique eusocial lifestyle with strictly determined social roles and cooperative breeding
within the colony. The anatomy of MR has several specific features, which probably
evolved as an adaptation to living underground in oxygen limiting conditions, including
underdevelopment of the visual system [168], skin insensitivity [169], and ability to
tolerate low temperature [170] and low oxygen levels [171]. MRs are also characterized by
a decreased metabolic rate, which is associated with reduced levels of thyroid hormones
[167]. One of the most remarkable features of MR is that none of the autopsies of dead
animals in several colonies revealed cancer incidence [165]. Moreover, primary fibroblasts
derived from MR were sensitive to contact inhibition [172], resistant to experimentally
induced tumorigenesis and unable to form xenograft tumors [173].
MR poses a challenge to the theories that link aging, cancer and oxidative stress.
Since MR lives in low oxygen conditions, it is expected to have low levels of oxidative
stress. However, research showed that MR is characterized by significant oxidative
damage. Compared to mice, MRs have lower GSH/GSSG ratio, higher rate of lipid
peroxidation, high rate of DNA oxidative damage and higher protein carbonylation [174].
It was also demonstrated that MR proteins possess higher levels of protein thiols, increased
protein stability, increased resistance to urea-induced denaturation and elevated
proteasomal activity, while also showing lower levels of protein ubiquitination. Moreover,
unlike the mouse proteome, the MR proteome did not show significant age-related
susceptibility to oxidation and ubiquitination [175]. A separate study did not detect agerelated changes in the activities of antioxidant enzymes, including Mn superoxide

85

dismutase (SOD), Cu/Zn SOD, and catalase, and also observed low glutathione peroxidase
(GPx) activity [176].
Mammals have eight GPxs, including five selenoproteins. GPx1 is the first
identified and one of the best studied selenoproteins [1]. This and other selenoprotein GPxs
have selenocysteine (Sec) residues in their active sites. GPx1 is a cytosolic enzyme and the
most abundant selenoprotein in mammals. Other GPxs show different cellular localizations
and/or tissue and substrate specificities [11, 177]. GPx1 is not an essential enzyme, i.e.,
GPx1 knockout mice are viable and fertile. However, they are more susceptible to
oxidative stress [58, 178] and viral myocardites [179]. Expression of GPx1 is decreased in
prostate cancer and breast cancer cell lines [180], as well as in the mouse model of liver
cancer [181]. A single nucleotide polymorphism that changes Pro to Leu at the codon 198
of human GPx1 is associated with lung [182] and bladder [183] cancers.
Currently, there is no information on the utilization of selenium (Se) by MR;
however, this is an essential trace element in mammals and its supplementation may be
beneficial in cancer chemoprevention [184]. Se functions mostly through incorporation
into proteins in the form of Sec. Mice and humans have 24 and 25 selenoprotein genes,
respectively [10]. However, nothing is known about the composition of the MR
selenoproteome.
In this study, we observed low levels of Se in MR tissues. This observation led to
the finding that the reduced utilization of Se by this organism was due to a specific defect
in GPx1 expression.
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4.3 Experimental Procedures
Animals. Animal experiments were approved by IACUC committees at University
of Illinois at Chicago and University of Nebraska-Lincoln. To carry out ICP-MS analyses,
western blotting, activity assays and other analyses, animals were sacrificed, their tissues
frozen in liquid nitrogen and stored until use. To prepare extracts, tissues were
homogenized in PBS supplemented with a protease inhibitor cocktail (Sigma). Cellular
debris was removed by centrifugation at 13,000 rpm for 15 min at 4 °C, and protein
concentrations were determined by the Bradford assay.
Tissue samples for X-ray fluorescence microscopy (XFM). Tissues from
C57BL/6 mice and MRs were extracted and prepared at the same time to match
preparation conditions. Mice were fed standard rodent chow diet. MRs were fed either a
sweet potato or carrot diet. Tissues from a 1 year old MR were compared with the
corresponding samples of a 2 month old mouse to adjust for lifespan differences. All
freshly extracted tissues were washed in PBS and placed in 4% neutral buffered
formaldehyde in PBS for fixation. After 12 h, tissues were transferred to PBS, paraffin
embedded, and cut using a standard microtome into 5 µm sections. Sections were mounted
on silicon nitride windows (2 x 2 mm; 200 nm thickness, Silson, Blisworth, UK). Light
microscopy images were taken using a Leica DMXR microscope (Leica Microsystems,
Bannockburn, IL).
XFM. Trace elements in mouse and MR tissue samples were imaged with XFM at
the Advanced Photon Source (APS), Argonne National Laboratory (Argonne, IL). For
each pixel, full X-ray fluorescence spectrum was recorded using a single-element silicon
drift detector (Vortex EX, SII Nanotechnology, Northridge, CA). Dwell time varied from
1.1 sec to 4 sec per pixel. For quantification, each set of experiments was followed by
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recording X-ray fluorescence spectra of thin-film standards NBS-1832 and NBS-1833
(National Bureau of Standards, MD). X-ray fluorescence spectra for each sample were
fitted and quantified using data derived from standards. Image processing and analysis
were performed using MAPS software [185]. Each X-ray fluorescence image represents
2D distribution of the element.
Activity assays. Total GPx activity was measured using a GPx activity kit (Sigma)
according to manufacturer’s instructions. Methionine-S-sulfoxide reductase (MsrA) and
methionine-R-sulfoxide (MsrB) activities were measured in an HPLC assay as described
[186]. Briefly, 200 µg of total protein were added to a reaction mixture that was kept at 37
°C for 30 min in the presence of 20 mM DTT and either 200 µM dabsyl-methionine-Ssulfoxide (to assay for MsrA activity) or 200 µM dabsyl-methionine-R-sulfoxide (to assay
for MsrB activity). After stopping the reaction by adding 200 µl acetonitrile, it was
centrifuged at 4 °C for 15 min at 13,000 rpm and the supernatant (50 µl) was injected onto
a C18 column (ZORBAX Eclipse XDB-C18) to quantify the resulting dabsylated
methionine.
Splenocyte isolation and

75

Se metabolic labeling. After dissection, spleen was

immediately transferred into ice-cold DMEM and mashed through a 45 µm cell strainer
into the 50 ml tube. Cells were centrifuged at 800 g for 5 min. The pellet was resuspended
in 5 ml of ASK buffer (GIBCO) and incubated at room temperature for 5 min. Cells were
then diluted with DMEM and pelleted at 800 rpm for 5 min. The resulting pellet was
resuspended in 15 ml DMEM supplemented with 10% fetal bovine serum (GIBCO),
Antibiotic/Antimicotic (GIBCO), 0.4 mM glutamine and freshly neutralized 75Se selenious
acid (specific activity 1000 Ci/mmol, final concentration in the medium 1 nM), and pooled
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into a 15 cm plate. After 24 h, cells were washed 3 times with ice-cold PBS, and lysed in
CellLytic buffer (Sigma). Protein extracts were analyzed by SDS-PAGE followed by
autoradiography.
Whole transcriptome sequencing and assembly of selenoprotein genes.
Extraction of the total RNA from MR liver was carried out using a RNAqueous kit
(Ambion) according to the manufacturer’s instructions. DNA was removed by treatment
with DNAse I (Ambion). Liver transcriptome was sequenced at the University of
Nebraska-Lincoln genomic facility on an Illumina instrument. To assemble 35 bp reads
into longer contigs, three different strategies were used. First, mapping reads to reference
sequence from mouse or guinea pig genomes was performed using MAQ package 0.7.1
[http://maq.sourceforge.net/]. Second, SOAP package 1.03 [http://soap.genomics.org.cn/]
was used for de novo assembly of short reads. Finally, we employed an in-house program
that was optimized for assembling selenoprotein genes and utilized the variety of
information available from MAQ and SOAP output, as well as known sequences from
other rodents.
Inductively-coupled plasma mass spectrometry (ICP-MS). Quantitative
analyses of trace elements in animal tissues were performed using ICP-MS. Freshly frozen
mouse and MR tissues were homogenized and sonicated in PBS with Complete protease
inhibitor cocktail (Roche, Basel, Switzerland) (1 tablet in 50 ml PBS). Samples were
normalized to protein content in each lysate as determined using Bradford Protein Kit
(Bio-Rad, Hercules, CA). Samples were digested in 15% nitric acid, 15% hydrogen
peroxide for 2 h at 70 °C. 50 ppb gallium were added as an internal control to the digestion
mix. After digestion, samples were diluted 10 times with deionized water and analyzed by
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ICP-MS. Elemental analysis was performed at the University of Nebraska-Lincoln
Spectroscopy Core Facility using an Agilent Technologies ICP-MS Model 7500ce (Santa
Clara, CA) and an Elemental Scientific Inc. (Omaha, NE) SC4 autosampler. Each sample
was analyzed in triplicate. The carrier and make-up gas flows were 0.95 and 0.15 L/min of
Ar, respectively. The collision cell operated with 3.5 mL/min of H2 and 1.5 mL/min He for
reaction/collision mode. Dwell times for all elements were 0.3 s. except 78Se, for which the
dwell time was set at 0.9 s. Gallium (m/z = 71) was added to all samples and standards as
an internal standard at 50 ppb.
Expression constructs for mouse and MR GPx1 and their mutants. Mouse and
MR GPx1 cDNAs containing the 3’-UTRs including SECIS elements were amplified by a
two step PCR with primers that introduced Myc-tag into ORFs. Primers were designed as
follows: mouse: 1st round, 5’-CTCAGAGGAGGATCTCTGTGCTGCTCGGCTCTCCG3’ and 5’-GCATACTCTAGACTGATATTCAGCACTTTATTCTTAGTAGTGAAACC3’, 2nd round, 5’-CTCAGAGGAGGATCTCTGTGCTGGTCGTTTGGCCGCGGCC-3’ 5’GCATACTCTAGACTGATATTCAGCACTTTATTCTTAGTAGTGAAACC-3’; MR: 1st
round, 5’-CTCAGAGGAGGATCTCTGTGCTGGTCGTTTGGCCGCGGCC-3’ and 5’GCATACTCTAGAACACCCAGCACTTTATTAGAGGGTAATCATTTTGG-3’,

2nd

round, 5’-GCATACTCTAGAACACCCAGCACTTTATTAGAGGGTAATCATTTTGG3’ and 5’-ATGACATCTCGAGATGGAGCAGAAGCTCATCTCAGAGGAGGATCTC3’. The PCR products were digested with XhoI and Xba and ligated into a similarly
digested pCIneo vector. In the case of mouse GPx1, an early premature stop codon was
introduced using site-directed mutagenesis with QuikChange kit (Stratagene) and primers
5’-GAAACCCTGCTGTCCTAGCAGTCTGGCAAC-3’

and

5’-
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GTTGCCAGACTGCTAGGACAGCAGGGTTTC-3’.

The

resulting

mutant

was

designated as the M-short form. To rescue the early stop codon in MR GPx1, we
performed

site-directed

mutagenesis

with

AAGCCCTACTCACTCAGGGGCGCGGCCCTG-3’

primers

5’-

and

5’-

CAGGGCCGCGCCCCTGAGTGAGTAGGGCTT-3’, and the resulting mutant was
designated as the MR-long form. To obtain cysteine mutants of mouse and MR GPx1, we
used site directed mutagenesis with primers 5’-TCGCGTCTCTCTGCGGCACCACGAT3’ and 5’-ATCGTGGTGCCGCAGAGAGACGCGA-3’ for mouse GPx1, and 5’GAATGTGGCATCCCTCTGCGGCACCACGGTC-3’

and

5’-

GACCGTGGTGCCGCAGAGGGATGCCACATTC-3’ for MR GPx1. To obtain a
pBudGE/GFP construct, EGFP was amplified from pEGPFN3 vector with primers 5’ATGACAAGCTTATGGTGAGCAAGGGCGAGG-3’

and

5’-

GGACATTCTAGATTACTTGTACAGCTCGTCC-3’. The resulting PCR product was
ligated into a similarly digested pBudCE4.1 vector. Mouse and MR GPx1 mutants were
amplified

from

pCIneo

constructs

with

primers

GGTACCATGGAGCAGAAGCTCATCTCAGAGG-3’,

5’5’-

GCATACGCATACAGATCTCTGATATTCAGCACTTTATTCTTAG-3’

and

5’-

GGTACCATGGAGCAGAAGCTCATCTCAGAGG-3’, 5’-AGATCTACACCCAGCACTTTATTAGAGG-3’

respectively.

Cys

mutants

GGTACCATGGAGCAGAAGCTCATCTCAGAGG-3’
GCATACAGATCTTTAGGAGTTGCCAGACTGC-3’
GGTACCATGGAGCAGAAGCTCATCTCAGAGG-3’

were

amplified

with

and
(mouse)
and

5’5’-

and

5’5’-

GCATACAGATCTCTATGCAGGGCCGCGCCCC-3’ (MR), and inserted into the vector
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without the 3’-UTR. To express mouse and MR GPx1 mutants in a bacterial expression
system,

GPx1

mutants

were

amplified

with

ATGCATCATATGGAGCAGAAGCTCATCTCAGAGG-3’
GCATGCTCGAGTTAGGAGTTGCCAGACTGC-3’
ATGCATCATATGTGTGCTGGTCGTTTGGCCG-3’

primers
and

(mouse)
and

5’5’-

and

5’-

5’-GCATG

CTCGAGCTATGCAGGGCCGCGCCCC-3’ (MR) and cloned into pET28a expression
vector at NdeI and XhoI sites.
To clone mouse and MR GPx1 into pSelExpress1 (described in [187]), mouse and
MR

GPx1

coding

sequences

were

amplified

ATGACATAAGCTTATGGAGCAGAAGCTCATCTCAGAGG-3’
GCATACTCTAGATTAGGAGTTGCCAGACTGC-3’

(mouse)

ATGACATAAGCTTATGGAGCAGAAGCTCATCTCAGAGG-3’

with
and
and

5’5’5’5’-

GCATACTCTAGACTATGCAGGGCCGCGCCCC-3’ (MR) primers, digested with
HindIII and XbaI restriction endonucleases and ligated into pSelExpress1 vector. To swap
mouse and MR 3’-UTRs, we prepared the corresponding constructs on the basis of the
pBudCE4.1/GFP vector, which expressed Myc-tagged GPx1 and GFP from separate sites
in the construct.
Cell culture, transfections, metabolic labeling, immunoprecipitation and
western blot analyses. HEK 293 and HeLa cells were cultured in DMEM supplemented
with 10% FBS, 100 units/mL penicillin, and 100 units/mL streptomycin. All transfections
were performed with Lipofectamin transfection reagent (Invitrogen), according to the
manufacturer’s manual. Eighteen hours after transfection, medium was replaced with the
one containing freshly neutralized

75

Se selenious acid (specific activity 1000 Ci/mmol,
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final concentration in the medium 1 nM). Cells were labeled for 24 h and cellular extracts
analyzed by SDS-PAGE followed by autoradiography. For immunoprecipitation, HEK 293
cells were grown on 10 cm plates, transfected with various GPx1 constructs and
metabolically labeled with

75

Se. Cells were resuspended in PBS, supplemented with

protease inhibitor cocktail (Sigma) and treated with a tissue homogenizer. 600 µg of total
protein were subjected to immunoprecipitation with the Protein G Immunoprecipitation Kit
with mouse anti-Myc antibodies (Invitrogen), according to the manufacturer’s instructions.
For western blot analyses, samples were separated on 10% Bis-Tris gels, transferred onto
PVDF membranes, and incubated with mouse anti-Myc (Invitrogen) or anti-GFP (Sigma)
antibodies.
RNA isolation and quantitative PCR. To compare GPx1 expression levels in
mice and MRs, total liver RNA was isolated by TRIZOL extraction according to the
manufacturer’s instructions. Genomic DNA was removed using a DNA removal kit
(Ambion). RNA concentration was measured spectrophotometrically and cDNA was
obtained with Superscript III Reverse Transcriptase (Invitrogen) using the oligo dT primer.
Real time PCR was performed using a Fast SYBR Green Master Mix (Applied
Biosystems). Primer sequences for the GPx1 expression analysis were as follows: mouse,
5’-CAGGAGAATGGCAAGAATGAAG-3’ and 5’-GAAGGTAAAGAGCGGGTGAG3’;

and

MR,

5’-GACACCAGGAAAACGCAAAG-3’

and

AAGGTGAAGAGCGGATGTG (primers were based on the assembled transcriptome
sequences). GPx1 expression was normalized to that of aldolase. Primers for aldolase
expression were as follows: mouse, 5’-GTGATCCTTTTCTACGAGACCC-3’ and 5’-
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ACCACAATTCCCTTCTCCTTG-3’; and MR, 5’-AAGATGGGTGTGACTTTGGG-3’
and 5’-GGTACTAGCCCATTCTGTTGAC-3’.
Additional analyses of mRNAs. RNA was isolated from cells transfected with
various GPx1 constructs inserted into pBudCE/GFP vector. It was then treated with
RNAse free DNAseI (Fermentas). The resulting RNA samples were reverse transcribed
with a SuperScript VILO cDNA synthesis kit (Invitrogen). Quantitative PCR was
performed using a Fast SYBR Green Master Mix (Applied Biosystems). To distinguish
recombinant GPx1 from the endogenous form, we used the direct primer specific for Myctag (5’-TCATCTCAGAGGAGGATCTC-3’) and reverse primers as follows: 5’TGAGCCTTCTCACCATTCACTTCG-3’

(mouse)

and

5’-

CGAGCACTACCAGGCCTCTGG-3’ (MR). Expression of GPx1 mutants was normalized
to EGFP expressed from the same vector. Primers for EGFP were as follows: 5’TCAAGGACGACGGCAACTAC-3’ and 5’-TTGTGCCCCAGGATGTTGCC-3’.
Protein isolation and activity assays. Recombinant cysteine GPx1 mutants were
expressed in BL21(DE3) cells (Novagen). E. coli cells were transformed with various
GPx1 constructs and the cells grown until an OD of 0.6 at 600 nm. Protein expression was
induced overnight with 1 mM IPTG. Cells were harvested by centrifugation, homogenized
in 50 ml of PBS supplemented with Protease Inhibitor Cocktail EDTA-free (Roche) and
sonicated on ice for 20 min. The suspension was centrifuged at 9,000 rpm and the resulting
lysates were assayed for protein concentration and fractioned on TALONTM column
(Clontech). Fractions containing GPx1 mutants were dialyzed against PBS and subjected
to activity assays using a GPx kit (Sigma).
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4.4 Results
Low levels of Se in MR tissues. We analyzed the levels and distribution of Se in
various tissues of MR, H. glaber. Mouse tissues were used for comparison as mice are
rodents of similar size. Paraffin-embedded tissue sections were first imaged using
synchrotron XFM. Se was uniformly distributed in liver (Fig 17A), heart and lung tissues
in both organisms. Mouse testes are known to accumulate Se in elongating spermatids
[188]. However, such Se enrichment was not observed in MR testes (Fig 17B). Most MR
tissues had considerably lower Se levels (30-75% lower). However, MR and mouse brain
samples had similar Se contents. Brain is known to retain Se during deficiency [128].
To verify the XFM observation of low Se in MR tissues, we measured Se in MR
and mouse tissues using ICP-MS. All MR tissues analyzed, except brain, had lower Se
levels than the corresponding mouse tissues (Fig 17C). The major Se pool in mice is in the
liver; however, MR liver had low amounts of Se. Thus, MR is characterized by apparent
Se deficiency.
Low GPx activity in MR tissues. Since Se mostly occurs in the form of Sec in
proteins, the low Se in MR tissues suggested a decreased expression of selenoproteins. To
test this hypothesis, we assayed methionine sulfoxide reductase and GPx activities.
Mammals have three MsrBs including the selenoprotein MsrB1, which is the major MsrB
in mouse liver [16]. Since it is responsible for MsrB activity in the cytosol and nucleus
(MsrB2 and MsrB3 are mitochondrial and endoplasmic reticulum proteins, respectively), it
is likely the main MsrB in all mammals. MsrB1 expression and activity (as well as total
MsrB activity) depend on dietary Se. Mammals also have a single MsrA, which is not a
selenoprotein. We found that both MsrA and MsrB activities were similar in mice and
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MRs (Fig 18A, B). Thus, low Se in MR tissues cannot be explained by uniform
selenoprotein deficiency.
GPx1 is a major mammalian GPx, which is, like MsrB1, easily regulated by dietary
Se. We found extremely low GPx activity in MR liver compared to the corresponding
mouse tissue (Fig 18C). Low Se in the liver correlated with low GPx activity, which was
suggestive of low GPx1 expression.
Sequencing and analysis of the MR liver transcriptome. Several rodent genomes
were sequenced in recent years, but the genome of MR is not available. To characterize
selenoprotein occurrence in MRs, we performed sequencing of the MR liver transcriptome
using Illumina technology. Overall, 25,011,515 36-bp-long reads were obtained and
assembled into contigs. The length distribution of assembled contigs is shown in Fig 19A.
The best results were obtained using k-mer size of 23, wherein 395,038 contigs were
generated, with 40,073 contigs longer than 100 bp, and 379 contigs exceeding 1,000 bp.
Occurrence of selenoprotein genes was then examined, and we detected 15
selenoprotein sequences. This analysis suggested that the MR selenoproteome is similar to
that of other mammals. Schematic representation of the human selenoproteome (which
contains 25 selenoproteins) is shown in Fig 19B, with MR orthologs identified in the
current study highlighted. The lack of some selenoprotein genes was likely due to
insufficient sequencing depth, but it also could be an indicator of their low expression in
MR liver. Overall, even though Se levels and GPx activity were low in MR liver, this
organ expressed many selenoprotein mRNAs, and the majority of these sequences had no
unusual features.
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SelP is the only mammalian selenoprotein that contains more than one Sec and it
has two SECIS elements in the 3’-UTR. Mammalian SelPs generally have 10-15 Sec
residues, e.g., 10 Sec in human, mouse and rat SelPs [38]. However, we found only 7 Sec
residues in MR SelP (Fig 20). Together with SelP from Cavia porcellus, this is the lowest
Sec content of any vertebrate SelP.
In addition, we detected an unusual feature in MR GPx1: an early stop codon
present 5 codons upstream of the position terminating GPx1 synthesis in other mammals
(Fig 19C, 21). Thus, MR GPx1 was predicted to be 5 amino acids shorter than other
mammalian GPx1s. SECIS elements in MR selenoprotein genes satisfied the requirements
of a canonical eukaryotic SECIS model. Overall, it is likely that the MR selenoproteome is
not significantly different from that of other mammals, with the exception of SelP and
GPx1 sequences.
Low GPx1 expression in MR. To test for GPx1 expression levels, we isolated
mouse and MR splenocytes, metabolically labeled the cells with
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Se and they were

analyzed by SDS-PAGE followed by autoradiography (Fig 18D). It appeared that the
GPx1 band was missing in MR splenocytes. To test if low GPx1 expression and activity
were due to a low mRNA expression, GPx1 mRNA levels were examined by real-time
PCR. We found that the MR GPx1 mRNA was expressed at much lower levels than mouse
GPx1 mRNA in the liver (Fig 18E). Thus, the low GPx1 activity was, at least in part, due
to low GPx1 mRNA levels.
Reduced expression of MR GPx1 in transfected mammalian cells. An early stop
codon in MR GPx1 could also contribute to the low expression and activity of GPx1. To
test this possibility, we prepared constructs containing MR GPx1 with the early UAG stop
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codon, and the one, where UAG was replaced with CAG (encoding glutamine present in
mouse GPx1 at this position). As a control, we prepared mouse GPx1 and its mutant, in
which the CAG codon was changed to UAG (Fig 22A). The constructs were transfected
into HEK 293 cells, which were then labeled with
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Se and analyzed for selenoprotein

expression patterns (Fig 22C, upper panel). The same membrane was also subjected to
western blot analysis with anti-Myc antibodies (Fig 22C). To distinguish from the
endogenous GPx1, proteins were immunoprecipitated with anti-Myc antibodies and
analyzed on a gel (Fig 22C, lower panel). Expression levels of MR GPx1 were much lower
than that of mouse GPx1. Introduction of CAG in place of UAG further decreased MR
GPx1 expression. At the same time, substitution of CAG with UAG in mouse GPx1 did
not decrease GPx1 expression.
In addition, mouse and MR GPx1 forms were cloned into a pBudCE4.1 vector,
containing GFP under CMV promoter. In further experiments, GFP was used as an internal
control for transfection and protein loading. Inhibition of proteasome in HEK 293 cells did
not rescue MR GPx1 expression (Fig 22D). In addition, real time PCR analysis revealed no
difference between mouse and MR GPx1 mRNA after transfection (Fig 22B). Thus, MR
GPx1 expression was suppressed regardless of the early stop codon. However, substitution
of Sec with cysteine partially rescued expression of MR GPx1 (Fig 22E). These data
suggest that incorporation of Sec may limit GPx1 synthesis. We also checked if the early
stop codon in MR GPx1 affects peroxidase activity of this enzyme by expressing Cyscontaining His-tagged MR and mouse GPx1s in bacteria. These mouse and MR GPx1
proteins had similar activities (Fig 23). These data suggest that the early stop codon neither
affects expression nor activity of the enzyme, and that the low expression of MR GPx1 is
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due to a combination of low mRNA levels and decreased Sec insertion. These two factors
may be linked, e.g., inefficient Sec insertion may destabilize GPx1 mRNA.
SECIS element in MR GPx1 is not responsible for low GPx1 expression. Sec
insertion includes recognition of the SECIS element in the 3’-UTR of selenoprotein
mRNAs by SBP2 and subsequent recruitment of additional factors, such as EFSec and
tRNASec[Ser], which insert Sec in response to the UGA codon. Efficiency of Sec
incorporation may depend on additional features, such as the position of the UGA codon
within the ORF and the type of SECIS element. Alignment of GPx1 SECIS elements
revealed a nucleotide substitution in the conserved SBP2 binding site (Fig 24A). However,
comparison of MR (Fig 24B) and mouse (Fig 24C) SECIS elements in GPx1 did not show
unusual features in the MR SECIS element, suggesting that the predicted structure may
support Sec incorporation.
To directly test if the MR GPx1 SECIS element is responsible for the low GPx1
expression, we cloned coding sequences of mouse and MR GPx1s into pSelExpress1
vector containing a highly efficient eukaryotic SECIS element [187]. Analysis of these
expression constructs (containing the same SECIS element) by metabolic
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Se labeling of

transfected HEK 293 cells showed that the MR GPx1 was still expressed at a low level
compared to mouse GPx1 (Fig 24D). To further examine the role of SECIS elements as
well as the entire 3’-UTRs in GPx1 expression, we prepared constructs that swapped the
3’-UTRs between mouse and MR GPx1s. These constructs were expressed in HEK 293
cells, followed by
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Se labeling and Western blot analysis (Fig 24E). Substitution of the

MR GPx1 3’-UTR with the mouse one did not increase MR GPx1 expression; in addition,
replacement of the mouse GPx1 3’-UTR with the MR one did not decrease the expression
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of mouse GPx1. Thus, neither SECIS element nor the 3’-UTR were responsible for the
reduced MR GPx1 expression. It is an attractive possibility that the overall GPx1 mRNA
structure modulates the rate of Sec incorporation.
Absence of GPx1 decreases Se levels in mice. GPx1 is the most abundant
selenoprotein in mouse liver and kidney. We tested if removal of this protein could affect
Se levels in tissues by examining WT and GPx1 knockout mice. Se levels in GPx1
knockout mice were almost twice lower than those in WT livers (Fig 25) (p = 0.00387) and
kidneys (p = 0.0409). However, in tissues characterized by lower GPx1 levels, such as
spleen, heart, lung, and brain, Se levels were not affected by GPx1 knockout. Thus, the
absence of GPx1 could indeed be responsible for the reduced Se use by MRs.
GPx1 expression in long lived rodents. To examine if the aberrant expression of
MR GPx1 has evolutionary aspects, we analyzed its levels in primary skin fibroblasts
derived from long-lived rodents, including white footed mouse, chipmunk, vole, single fox
squirrel, beaver and porcupine, and also examined fibroblasts from another long-lived
mammal, little brown bat [189]. Cells were metabolically labeled with
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Se, and proteins

analyzed by SDS PAGE followed by autoradiography (Fig 26). HEK 293 cells were used
as a positive control, and mouse embryonic fibroblasts derived from GPx1 knockout mice
as a negative control. All analyzed species, except porcupine, had a strong band
corresponding to GPx1. In the case of porcupine, we observed a weak
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Se signal in the

GPx1 position and a stronger band that migrated faster than GPx1. Sequence analysis of
GPx1 in these rodents should await the availability of their genome sequences. However,
examination of the phylogenetic tree indicated that MR and porcupine share a common
ancestor (Fig 26B), whereas other examined mammals are more distant. Thus, it appears
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that the defect in GPx1 expression may not be limited to MR and may occur in a subset of
rodents.

4.5 Discussion
GPx1 is an abundant glutathione peroxidase in mammals. It plays an important role
in the protection of cells from oxidative stress by reducing hydrogen peroxide with
glutathione. Surprisingly, we found that GPx1 is essentially absent in MR tissues, while
other selenoproteins are expressed at normal levels and/or are enzymatically competent.
Sequencing and analysis of the MR liver transcriptome detected GPx1 mRNA, but it was
present at low levels and had an early termination codon. Further analyses revealed that the
low expression was likely due to a combination of low mRNA levels and decreased
insertion of Sec rather than due to compromised GPx1 activity caused by premature
termination.
It was reported that GPx1 is the most abundant liver selenoprotein. In rat liver, it
accounts for 63% of the total Se [190]. Se deficiency induces rapid degradation of GPx1
mRNA (and several other selenoprotein mRNAs), while the expression levels of several
additional selenoproteins are preserved under these conditions [191]. GPx1 was proposed
as a biomarker of Se utilization, since its activity is very sensitive to Se dietary status. It
was also suggested that GPx1 is a “Se buffer”, wherein this enzyme stores Se and provides
this element for biosynthesis of selenoproteins during Se deficiency [192]. On the other
hand, GPx1 knockout does not affect expression of other selenoproteins [78, 193]. This
enzyme is also not essential: GPx1 knockout animals are viable; however, they are more
susceptible to oxidative stress and show defects in redox signaling [194]. These data
correlate with previously reported increases in oxidative stress parameters in MR,
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including a low GSH/GSSG ratio, high rate of DNA oxidative damage, and increased
protein carbonylation and lipid peroxidation [174]. Moreover, both GPx1 knockout mice
and MRs showed abnormal blood glucose regulation [78, 193]. These mice had a normal
fasting glucose, but reduced blood insulin levels [194, 195]. However, unlike GPx1
knockout mice, MR also showed abnormal glucose tolerance (glucose levels remained
elevated for prolonged periods of time) and insulin sensitivity (glucose levels immediately
decreased upon insulin administration and remained low for prolonged periods of time)
[176, 196]. In addition, GPx1 knockout mice had reduced islet β-cell mass in pancreatic
tissue [195], while MR had different abundances of the four distinct types of islet cells.
Even though the abnormal glucose regulation may be relevant to MR adaptation to its
specific lifestyle, it could be, at least in part, due to an abnormal GPx1 function.
Se levels in animal tissues vary depending on many factors, including the
requirements of the organism for this trace element and the diet. Numerous studies
reported on the role of dietary Se in human health. For example, Se deficiency may cause
endemic cardiomyopathy (Keshan disease), liver degeneration observed in rats and pigs,
and white muscle disease in ruminants and turkeys [184, 197]. None of the Se deficiencyinduced pathologies have been reported for MR. In this regard, it is particularly interesting
that MRs have never been observed to develop cancer [166]. We compared trace element
profiles in control and GPx1 knockout mice, and found a significant decrease of tissue Se
levels in liver and kidney. Somewhat similar differences in Se levels were observed
between mouse and MR. GPx1 is the most abundant selenoprotein, especially in liver and
kidney, and the GPx1 knockout data suggest that this protein accounts for approximately
half of Se in these organs.
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We also observed significant differences in Se in spleen, lungs and testes (these
tissues depend on Se provided by SelP). This selenoprotein is the only mammalian protein
that contains multiple Sec residues [38]. Previously, we suggested that the number of Sec
residues in SelP might be used as an indirect genetic marker of Se utilization [198]. In
rodents and primates, the Sec content of SelP is almost twice as low as in aquatic
vertebrates. Comparison of rodent SelPs shows that C. porcellus and MR SelPs have 7 Ser
residues, which is the lowest number of SelP Sec residues in vertebrates. MR, porcupine
and C. porcellus are closer to each other and are more distant to other rodents, such as
mice, rats and rabbits [199]. Our analysis of GPx1 expression suggested a decreased GPx1
expression in MR and porcupine, and previous research revealed low GPx1 activity in C.
porcellus [200]. Overall, these data suggest a possible loss of GPx1 function in this
specific group of rodents and, as a consequence, a reduced requirement for Se by these
organisms. It is remarkable that such an important selenoprotein is compromised in these
animals, which survived for tens of millions of years essentially without GPx1.
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Figure 17. XFM and ICP-MS analysis of Se in mouse and MR tissues. XFM
scans of mouse and MR livers (A) and testes (B). Each element and its maximum and
minimum threshold values are given above each image in ng/cm2. The rainbow-colored
scale bar relates to the signal intensity measured as ng/cm2 in each spot with dark pixels
representing areas of low concentration and a gradient to bright pixels depicting increasing
concentrations. A scale bar is shown below the elemental maps. (C) Se was analyzed by
ICP-MS in mouse and MR tissues. Values are means +/- SD. Organs in which trace
elements were analyzed are shown below each panel (*p<0.05).
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Figure 18. MR tissue extracts have low GPx1 expression and activity. Total
MsrB (A), MsrA (B) and GPx (C) activities were measured in indicated mouse and MR
tissues. (D) Primary splenocytes derived from MR and mice were metabolically labeled
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with 75Se and protein extracts were analyzed by SDS-PAGE followed by autoradiography.
The band corresponding to GPx1 is shown with an arrow on the right. (E) Relative
expression of GPx1 mRNA in MR and mouse liver (* p<0.05).
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Figure 19. Transcriptome analysis and characterization of the MR
selenoproteome. (A) Length distribution of assembled contigs of the MR liver
transcriptome. (B) Selenoproteins identified in MR. The human selenoproteome is used as
a reference to represent the MR selenoproteome. Selenoproteins identified by sequencing
the MR liver transcriptome are highlighted. Location of Sec residues is indicated by a red
line. Seven Sec residues were found in SelP. GPx1 has an early termination codon (see text
for details). (C) Schematic representation of MR GPx1 in comparison with mouse GPx1.
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Figure 20. Protein sequence alignment of SelP. The following sequences were used for
alignment construction (Genbank accession numbers): Homo sapiens (AAH58919.1);
Canis familiaris (NP_001108590.1); Sus scrofa (NP_001128295.1); Mus musculus
(AAH01991.2); and Rattus norvegicus (NP_062065.2). Selenocysteine residues are
highlighted in red, and cysteines in the positions corresponding to selenocysteine are
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shown in blue.

Figure 21. Protein sequence alignment of GPx1. The following sequences were
used for alignment construction (Genbank accession numbers): Homo sapiens
(NP_000572.2); Sus scrofa (NP_999366.1); Canis familiaris (NP_001108591); Rattus
norvegicus

(AAB95647.2),

Mus

musculus

(CAA27558)

and

Cavia

porcellus

(AAKN02012894.1). The selenocysteine residue is highlighted in red and indicated by an
asterisk. The early stop codon in the MR sequence is also highlighted in red.
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Figure 22. GPx1 is poorly expressed in mammalian cells. (A) Schematic
representation of MR and mouse GPx1 mutant constructs. Positions of Sec and glutamine
(CAG) codons, the stop signal (TAG) and the SECIS element in the 3'-UTR are shown. (B)
mRNA levels were assessed by real time PCR and normalized to GFP expressed from the
same vector. Results are given +/- SD. (C) MR and mouse Myc-GPx1 constructs were
transfected into HEK 293 cells. Cells were labeled with 75Se followed by SDS-PAGE and
autoradiography (upper panel). Migration of ectopically expressed GPx1 is shown on the
left. Same lysates were probed with anti-Myc and anti-β-actin antibodies (two bottom
panels). Myc-GPx1 mutants were also immunoprecipitated with anti-Myc antibodies,
followed by PhosphorImager analysis of the
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Se-labeled GPx1. (D) Mouse and MR

constructs were transfected into HEK 293 cells followed by treatment of cells with 10 µM
MG132 for 12 h. Cells were labeled with 75Se followed by protein analysis by SDS-PAGE

110

and autoradiography (upper panel). The same membrane was stained with Myc and GFP
antibodies. (E) Expression of mouse and MR cysteine mutants of GPx1 in HEK 293 cells
was analyzed by Western blotting. IP, immunoprecipitation. WB, western blotting.
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Figure 23. Expression of mouse and MR GPx1 in E. coli. Cysteine mutants of
MR and mouse GPx1 were cloned into pET28a and expressed in E. coli. (A) Proteins were
isolated from identical amounts of bacterial culture and aliquots were analyzed by SDSPAGE. (B) Glutathione peroxidase activity of MR and mouse GPx1 was measured and
normalized to the amount of protein in each sample. Results are given +/- SD.
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Figure 24. SECIS element does not decrease GPx1 expression level. (A)
Aligment of mammalian GPx1 SECIS elements. Nucleotides critical for the SECIS
function are underlined. (B) MR GPx1 SECIS element as predicted by SECISearch.
Functional sites are shown in bold. (24). (C) Mouse GPx1 SECIS element. Functional sites
are shown in bold. (D) Mouse and MR GPx1 coding sequences were cloned into
pSelExpress1 containing an efficient eukaryotic SECIS element and expressed in HEK 293
cells. Cells were labeled with 75Se followed by SDS-PAGE, autoradiography and Western
blotting with Myc antibodies. Coomassie staining is a loading control. (E) Coding
sequences of mouse GPx1 containing the MR GPx1 3’-UTR (M-long-MR SECIS) and
coding sequence of MR GPx1 containing mouse GPx1 3’-UTR (MR-short-M SECIS) were
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expressed in HEK 293 cells. Cells were labeled with

75

Se followed by SDS-PAGE,

autoradiography and Western blotting with Myc and GFP antibodies.

Figure 25. Reduction in Se levels in tissues of GPx1 KO mice. Se was
determined by ICP-MS in tissues from wild type (WT) and GPx1 knockout (KO) mice.
Values are means +/- SD. Organs in which Se was analyzed are shown below each panel
(** p<0.005, *p<0.05).
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Figure 26. Expression of GPx1 in skin fibroblasts of rodents and long lived
mammals. (A) Cells were labeled with 75Se followed by SDS-PAGE and autoradiography.
HEK 293 cells and MEFs derived from GPx1 KO mice were used as positive and negative
controls, respectively. Migration of the band corresponding to GPx1 is shown with an
arrow. (B) Schematic representation of the phylogenetic tree of rodents (adapted from
[199]).
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CHAPTER 5
Conclusions and future directions
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5.1 Roles of trace elements in regulation of the gastrointestinal
microbiome
Our results indicate the importance of the trace element Se in regulation of the
gastrointestinal microflora. Dietary Se increased diversity of microflora and differentially
affected various groups of microorganisms. These effects were more pronounced in
conventionalized mice, which might be explained by the fact that the contribution of the
pre-existing microflora was removed. The observed differential sensitivity to dietary Se
might be due to differences in Se utilization pathways among microorganisms [201]. On
the other hand, our study demonstrates that the intestinal microflora is an essential
intermediate between dietary Se and the host selenoproteome. This observation leads to
several questions that might be addressed in future studies. First, intestinal microflora
plays an important role in protecting a rapidly renewing intestinal epithelium from various
pathological processes, such as through induction of Toll like receptor (TLR) mediated
signaling. Induction of this pathway is critical in protecting intestinal cells from apoptosis,
which might be induced by exogenous injury or pathogenic infection [202]. At the same
time, GPx1 and GPx2 play a role in protecting intestinal cells from oxidative stress and
their removal is associated with severe pathology [203, 204]. Thus, a better understanding
of Se distribution between the host and microbiota may explain the beneficial role Se
supplementation under certain conditions. Second, it would be important to follow the
effect of Se-modified intestinal microflora on health parameters, which depends on
intestinal microflora, such as susceptibility to IBD, various intestinal infections, food
digestion and obesity. These experiments might be carried out using similar models we
applied in our study. Intestinal microflora in GF mice can be reestablished by intestinal
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extracts obtained from Se-deficient and Se sufficient mice. Finally, the observed effects
might not be limited just for Se. Other trace elements, such as Cu, Fe, Mn and Zn may also
play an important role in regulation of the intestinal microflora, and it might be an
interesting field in nutritional studies. Se has been the first trace element for which the role
of microbiota has been addressed, and these studies should be extended to other trace
elements.

5.2 Function of Sep15 in cataract formation
In our study, we characterized Sep15 KO mice and found them to consistently
develop nuclear cataracts. However, the underlying mechanism is still unclear. In addition,
Se-deficient mice (that are maintained on the Se deficient diet for one year) were not found
to develop cataracts (unpublished results). Sep15 participates in the glycoprotein folding
cycle, and Sep15 mRNA is enriched during lens development. One of possible
explanations of the nuclear cataracts, observed in the Sep15 KO mice, is the improper
folding of Sep15 targets, which may play a role in maintenance of lens integrity and
transparence. The next step in our understanding of Sep15 function in cataract formation
will be the identification of Sep15 targets in lens epithelial cells. To identify Sep15 targets,
we will apply in vivo target search model, since Sep15 is characterized by thioredoxin-like
fold and has a redox motifs, UxC (U is Sec). We will take advantage of the previously
developed reaction mechanism of this class of enzymes. One of Cys in the redox motif
serves as a nucleophilic attacking group, leading to the formation of a covalently-linked
intermediate. The other Cys has a resolving function: it releases the reduced product and
forms an intramolecule disulfide. A stardard approach to trap the substrates of thiol
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oxidoreductases is to mutate the resolving Cys to serine, that would allow a formation of
the intermolecular intermediate, but would prevent substrate release (Fig 27). We will
employ this approach to trap Sep15 targets and further sequence then by mass
spectrometry. Introduction of FLAG and HA tags on N- and C-termini will allow us to
perform large scale purification using FLAG/HA tandem purification kit, designed by
Sigma, i.e., I.P for one tag followed by Western blot identification with antibodies for
another tag. These mutants will be prepared in a vector that allows efficient expression in
mammalian cells. Previously, a similar approach was applied for Drosophila Sep15, which
contains a Cys in place of Sec. When such redox-inactive mutants were purified from
insect cells and immobilized on the column, no targets were identified. A possible
explanation is that, for proper function, Sep15 needs to be localized in the ER and/or
interact with UDP glucose:glycoprotein glucosyltransferase. To examine the interactions
under more natural conditions, we will express Sep15 (Fig 27B) in lens epithelial cells.
The Sep15 mutant proteins will contain the HA tag upstream of the ER-targeting signal
and the FLAG tag at the C-terminus. In SelM (homolog of Sep15) mutants, the FLAG tag
will be inserted upstream of the ER retention signal. Then, we will perform
immunoprecipitation with anti-HA antibodies. Samples will be applied to SDS-PAGE
under non-reducing conditions. This will allow us to identify mixed disulfides by Western
blotting with anti-FLAG antibodies. Later, the I.P. samples will be reduced with 10 mM
DTT, separated by SDS-PAGE, stained with Coomassie blue, and subjected to mass
spectrometry analyses. Targets identified during thus procedure will be verified in
subsequent in vitro experiments, and the interactions will be confirmed in a cell culture
system by co-immunoprecipitation. Both Cys- and Sec-containing versions of
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selenoproteins will be used. These proteins will be co-transfected into mammalian cells,
selenoproteins will be immunoprecipitated with antibodies against the tag, and the samples
will be probed with antibodies against the tag in the target protein, and, if available, against
the target protein itself.
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Figure 27. Experimental design for identification of substrates of Sep15. (A)
The active site of the thioredoxin-like fold protein Sep15 includes a CxU motif. In the CxU
motif, one residue (Sec) is the attacking residue, whereas the other residue (Cys) likely
completes the reaction by resolving the intermolecular disulfide. (B) The mutants of Sep15
designed for the in vivo target search experiment.
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5.3 Reduced utilization of Se by long lived animals
In our study, we found low levels of Se in MR tissues. Such reduced utilization of
Se can be explained by the low levels of the major mammalian selenoprotein, GPx1.
However, the exact reason for such dramatic reduction in expression is still unclear. We
examined several hypotheses, including the role of the premature stop codon and an
atypical SECIS structure; however, these factors did not explain the observed low
expression of GPx1. Interstingly, substitution of Sec with Cys rescued GPx1 expression,
by increasing the rate of translation. One additional hypothesis is associated with the
presence of rare codons in the sequence of the MR GPx1. The analysis of GPx1 expression
in long lived mammals, demonstrated the low expression of GPx1 in the porcupine.
Porcupine, MR and guinea pig are in the same branch of the evolutionary tree. Thus,
analysis of expression of porcupine and guinea pig GPx1 may be predicted to be low as
well. If so, comparison of the sequences of MR, porcupine and guinea pig GPx1 can reveal
common features (e.g., rare codons), that drastically decrease protein expression. Such
studies may help identify novel mechanisms of regulation of protein expression at the
translational level.
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